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INTRODUCTION 
 
Coronary artery disease (CAD) is a pathologic process that affects the coronary arteries 
resulting in its narrowing or complete blockage, and is most commonly caused by 
atherosclerosis. Atherosclerosis is the process by which cholesterol and fatty deposits build 
up along the inner walls of arteries resulting in its narrowing, thereby restricting blood flow 
to the muscles of the heart.  
In both developing and developed countries, coronary artery disease is one of the leading 
causes of mortality and morbidity. Although deaths due to coronary heart disease (CHD) 
have reduced over the past few decades, it is still the leading cause of death, accounting for 
17.3 million deaths per year. By 2030, this number is expected to increase to more than 
23.6 million(1). 80 % of global deaths due to CHD occurs in low and middle income 
countries(1). 
 
Indian Scenario: 
 
In India, the prevalence of CAD is extensive, both in rural and urban populations. The 
prevalence rates of CAD approaches ~ 11% in the urban population and ~7% in the rural 
population(2)(3). CAD has emerged as the leading cause of death in India. The mean age 
of presentation of CAD in our country is 5-6 years earlier than in the western population(4) 
and this is a cause of major concern(5). Therefore, preventive measures need to be 
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instituted early to delay onset of disease. It has also been noted that ischemic heart disease 
in India cannot be merely explained by the presence of traditional risk factors(6). There is 
evidence that in India and other developing countries, coronary artery disease is more 
prevalent among people belonging to the lower socioeconomic status(7).    
 
Basis of prevention and treatment of coronary artery disease: 
 
Risk stratification of patients plays a key role in the clinical management of patients as well 
as in preventing future disease. The concept of risk factors and its assessment was 
introduced by the Framingham Heart Study (FHS) several years ago. Risk factor 
assessment is the first step in primary prevention of CAD and also guides therapeutic 
management which is tailored according to the individual patients risk status(8).  
Few of the conventional risk factors for coronary artery disease include hypertension, 
diabetes, high cholesterol and LDL levels, low HDL levels, smoking, obesity, physical 
inactivity, age and postmenopausal status(in women) and family history of premature 
CAD(8). Framingham risk scoring systems along with NCEP risk grading categories 
predicts the probability of developing a coronary artery event in the next 10 years. These 
systems thereby justify the initiation of pharmacological therapy as primary prevention in 
those patients in those with high risk status (>20% risk of developing CAD in 10 years)(8)  
In most tertiary centers, a variety of investigations are used to diagnose CAD and plan their 
clinical management.  
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Noninvasive testing of atherosclerotic burden: 
 
Various noninvasive tests and imaging modalities have the potential to identify early 
coronary artery disease. These include exercise tolerance testing (ETT), stress 
echocardiography, SPECT scan, calcium scoring, cardiac CT and cardiac MRI. 
Non- invasive imaging modalities are efficient screening tools and help in detecting, 
measuring and monitoring CAD in asymptomatic individuals.  
Non-invasive modalities are more suitable for low / intermediate risk patients as they help 
identify those patients, who despite of their lower risk have significant coronary artery 
disease and are likely to require coronary revascularization. 
 
Gold standard: 
 
The gold standard for detecting and quantifying coronary artery disease is coronary 
angiogram (CAG). Often, majority of high risk patients directly undergo coronary 
angiogram to assess the need for revascularization procedures. 
 
Risk factor scoring systems and noninvasive imaging techniques – role in 
management 
 
Risk factor scoring systems thereby act as “gatekeepers” for noninvasive imaging 
techniques. This makes little sense as it has been well acknowledged that conventional risk 
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scoring systems have multiple limitations leading to under treatment of low risk patients 
with subclinical atherosclerosis(9) 
This illustrates the need for correlation between the conventional risk scoring systems and 
noninvasive modalities of testing for coronary artery disease.  
Coronary CT angiography (CCTA) is now used as a routine clinical tool to not only detect 
coronary artery stenosis but also a tool that can measure the severity and thereby quantify 
disease burden by quantifying stenosis, plaque volume and also further characterizing 
coronary artery plaque. Risk stratification processes primarily use traditional risk factors 
to guide management regarding prevention and treatment. A correlation between 
conventional risk scoring systems and findings on Coronary CT angiography would add 
significant value to the existing risk factor scoring systems in accurate prediction of 
coronary artery disease. Also it will validate these risk scoring systems as gate keeper’s for 
noninvasive imaging based on the individual’s risk estimate 
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AIMS AND OBJECTIVES  
 
Aim: 
 
To study the degree of correlation between conventional risk models as assessed by the 
Framingham Risk Estimates with National Cholesterol Education Program (NCEP) -Adult 
Treatment Panel (ATP) III guidelines, and coronary atherosclerotic disease burden as 
estimated on coronary CT angiography in a tertiary care hospital in South India  
 
 
Objectives: 
 
1. To determine the Framingham risk estimate and NCEP Core risk category among 
patients referred for a coronary CT angiography  
2. To assess the calcium score (CACS), segment involvement score (SIS), segment 
plaque score (SPS), segment stenosis score (SSS) and Modified dukes prognostic 
index (MDPI), which indicates disease burden, based on coronary CT angiography 
in the same group of patients  
3. To correlate burden of coronary artery disease as determined by the CT scores with 
the conventional risk scoring systems  
4. To describe plaque characteristics as non-calcified, mixed or calcified plaques based 
on their lipid, fibrous and calcium content.  
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REVIEW OF LITERATURE 
 
Coronary artery disease (CAD), a complex chronic inflammatory disease, is typically 
characterized by remodeling and narrowing of the coronary arteries which supply oxygen 
to the heart. Atherosclerosis is the main etio-pathogenic process that causes CAD. 
Atherosclerosis is a silent chronic and progressive process characteristically resulting in 
accumulation of lipids, fibrous elements and inflammatory molecules along and within the 
walls of arteries. The onset and progression of disease is multifactorial and an interplay 
between environmental and genetic factors (Figure 1)(10).  
Figure 1:Multifactorial interplay between environmental and genetic factors in the onset 
and progression of coronary artery disease 
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Pathophysiology of plaque formation: 
 
Atherosclerosis is a progressive process involving a vessel wall which ranges from early 
inflammatory changes in the vessel wall, lipid accumulation, minimal to severe plaque with 
calcification or rupture resulting in narrowing of the vessel lumen (Figure 2).  
Figure 2: Pathophysiology of plaque formation 
Image courtesy: essential interventional care.pdf – www.multimedicsllc.com 
 
The first step in plaque formation is the efflux of LDL into the subendothelial space. The 
LDL molecules then get modified and oxidized by various agents to cause monocyte 
adhesion, followed by their migration into the subendothelial space. These monocytes, on 
reaching the intima differentiate into macrophages. Macrophages act as scavengers of LDL 
and become foam cells. Foam cells cause surrounding inflammation by the release of 
various cytokines and inflammatory markers resulting in the formation of a fatty streak. 
Further progression results in migration of smooth cells from the media into the intima. 
These smooth muscles cells produce a fibrous cap. This fibrous cap covers the initial fatty 
 
I  
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streak. The foam cells within the fibrous cap become necrotic and release lipids which 
forms a necrotic core within the fibrous cap forming a fibrotic plaque.  
The thickness of the fibrous cap differentiates the plaque into a stable plaque and unstable 
plaque. A stable plaque has a thick fibrous cap and it protrudes into vessel lumen, 
producing flow limiting stenosis. Vulnerable plaques have a thin fibrous cap. They are 
hence prone to erosion and rupture. This exposes the core of the plaque to circulating 
proteins which cause thrombosis and sudden occlusion of the artery lumen. This usually 
causes an acute coronary syndrome.  
 
 
 
 
 
 
 
 
Figure 3: Depicts nonlinear atherosclerotic progression. Early plaque can lead to 
asymptomatic healing or erosion and lumen thrombosis and myocardial infarction. 
Repeated cycles of rupture and healing might lead to the more stable lesion with luminal 
narrowing and stable angina. Image courtesy: Veit Sandfort et al. Circ Cardiovasc 
Imaging. 2015;8: e003316 
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Epidemiology of coronary artery disease: 
 
Coronary artery disease as described earlier is the leading cause of mortality in the 
world(11). It is also the leading cause of death in India with its contribution to mortality 
rising with the rapid urbanization, change in lifestyle, physical inactivity and presence of 
other risk factors(3). India currently is in a state of epidemiological transition where the 
burden of communicable diseases have decreased and are replaced by an increasing 
prevalence of non-communicable diseases(12). The prevalence of CAD is extensive, both 
in rural and urban populations. The prevalence rates of CAD approaches ~ 11% in the 
urban population and ~7% in the rural population(2)(3). Indians are also shown to have a 
higher risk factor burden at much younger ages as compared to Western populations. 
Though earlier studies on migrant Indians suggested that conventional risk factors did not 
account for the high burden and premature onset of coronary artery disease, the large cross 
sectional INTERHEART study which recruited inhabitants from all continents and 52 
countries with a significant number of Indian subjects concluded that conventional risk 
factors did account for the significant CAD burden(13). However, for all practical 
purposes, all conventional risk prediction models used are developed in Western countries. 
There are currently no specific risk models that are based on Indian data. Western risk 
scoring systems may not be suitable for the Indian population and may actually 
underestimate CHD risk in Indians. Due to lack in evidence regarding risk based coronary 
artery disease prediction models in the Indian population, physicians do not have a choice 
but to adopt risk scoring systems used for western population.  
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Risk factors of coronary artery disease: 
 
Conventional risk factors for coronary artery disease were established by the Framingham 
heart study several years back. They can be divided into modifiable and non-modifiable 
risk factors. Modifiable risk factors include hypertension, diabetes, obesity, dyslipidemia, 
physical inactivity and smoking. Non modifiable risk factors are age, sex and family history 
of CAD.  
Risk stratifying algorithms and scoring systems: 
 
Risk stratifying algorithms are for use in healthy individuals to help guide prevention 
strategies. Risk factors for atherosclerosis and coronary artery disease(CAD), including 
age, sex, lipid levels, smoking, blood pressure and diabetes are incorporated in risk 
algorithms to predict an individual’s absolute risk for CVD in the general population.  
Various risk stratifying algorithms have been developed to suit various population groups 
in the world such as the Framingham Risk scoring system (USA), SCORE (Europe), 
PROCAM (Germany), ASSIGN (UK) etc.     
 
Widely used risk assessment tools like the Framingham risk score (FRS) or the National 
Cholesterol Education Program guidelines guide initial management of patients at risk for 
coronary artery disease. Based on the Framingham Risk Score (FRS) and the NCEP 
guidelines, a person with a <10% likelihood of developing a cardiac event in the next 10 
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years is considered to be low risk, while a person with a >20% risk of developing a cardiac 
event in the next 10 years is considered to be high risk. Although these risk factors are 
useful to predict risk in populations, their accuracy in predicting cardiovascular risk in 
individuals varies considerably across populations(14). This can potentially lead to patients 
in high risk CHD group with limited or no plaque to be treated to life-long drug therapy, 
and those with low risk CHD but with significant plaque might be undertreated or not 
treated at all.  
 
Each of these risk scoring algorithms have their own limitations, leading to inappropriate 
treatment especially in the setting of subclinical atherosclerosis. Thereby, as compared to 
risk estimation charts, imaging is probably superior in predicting the risk of a coronary 
event since:  
 Imaging allows direct visualization of coronary artery plaque as an evidence of 
atherosclerosis. This is better than identifying just risk factor exposure.  
 Re-classiﬁcation of low-risk subjects based on risk algorithms into a strata of higher 
risk if coronary artery disease is identified on imaging, will help guide therapy.  
 The identiﬁcation of patients with higher plaque will encourage and might improve 
adherence of patients to risk-modifying therapy(15). 
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Noninvasive imaging assessment of coronary artery disease:  
 
Figure 4 illustrates the capabilities of various imaging techniques (Fig 4A) to delineate 
each pathological correlate of CAD (Fig 4B). Optical coherence tomography (OCT) and 
intravascular ultrasound (IVUS) are modalities that are capable of detecting earliest phases 
of plaque formation such as the intimal xanthoma or pathological intimal thickening. These 
are however invasive methods. In contrast, computed tomographic (CT) calcium score 
imaging (non–contrast imaging) detects a later stage plaque with calcification. Coronary 
CT angiography (CCTA) can detect earlier lesions such as fibrous cap atheroma without 
calcification. 
 
Figure 4 A,B: Depicts nonlinear atherosclerotic progression as seen previously (B) with 
the imaging modality likely to pick up each of these stages of atherosclerosis. Image 
courtesy: Veit Sandfort et al. Circ Cardiovasc Imaging. 2015;8: e003316 
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Coronary CT angiography 
 
Coronary CT angiography (CCTA) has found its way into clinical practice as it is an 
accurate noninvasive method for the evaluation of coronary artery disease (CAD), stenosis 
severity, extent, and distribution of disease. Its greatest advantage is that is allows direct 
visualization of plaques, enabling its characterization, an advantage over conventional 
catheter coronary angiography which is the established gold standard.  
Figure 5:Clinical context for non-invasive and invasive diagnostic testing of patients with 
known or suspected ischemic heart disease, AHA 1999Patrick J. Scanlon et al. 
Circulation. 1999; 99:2345-2357 
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Coronary CT angiography has therefore replaced invasive cardiac catheterization in a 
selected group of patients (Figure5).  
 
What is CT coronary angiogram? 
 
It is a noninvasive test that uses computed tomography (CT) to image the beating heart. 
Good visualization of the coronary arteries and diseases affecting it enables accurate 
detection and grading of the stenosis. Also, it plays an important role in assessing other 
anomalies in individuals with suspected coronary artery disease. 
  
Rationale for imaging 
 
Imaging plays a role in screening of asymptomatic patients for subclinical or occult 
atherosclerotic disease which may not be detectable on conventional noninvasive testing. 
This is especially true in low and intermediate risk patients (16). Small group of 
asymptomatic patients with high risk factors may also benefit from this noninvasive 
imaging modalities. Preoperative screening for clearance in patients with suspected 
coronary artery disease undergoing non cardiac surgery is an established indication.  
 
CT coronary angiography has a high negative predictive value, and this is of significant 
clinical value in evaluation of patients with low or intermediate Framingham risk estimates 
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with atypical chest pain since there is considerable concern regarding the possibility of an 
underlying cardiac etiology for the chest pain. The need for an invasive coronary 
angiogram is obviated if the CT coronary angiogram is normal and calcium score is zero. 
In patients who present with atypical chest pain to the emergency department and identified 
to have acute coronary syndrome with low to intermediate risk features, CT coronary 
angiography is a quick, noninvasive test to “rule out” coronary artery disease. Also other 
causes of chest pain like acute pulmonary embolism and aortic dissection can also be 
excluded, by what is thereby popularly called the “triple rule out” study. This avoids 
unnecessary and expensive admissions for patients whose symptoms do not have a cardiac 
etiology(16).  
 
 
Patient preparation: 
 
Patient preparation prior to study is essential to obtain good quality images as well as 
reduce risk of possible adverse effects related to contrast and radiation dose.  
 
Heart rate control: 
 
Heart rate control is a significant part of patient preparation. Slow heart rates enable 
acquiring of images free of motion artefacts at points of minimal motion of the heart. Also 
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ECG gating is possible at slow and regular heart rates and thereby allows ECG gated dose 
modulation and subsequent reduction of radiation doses.  Heart rate of 55-65 beats per min 
is highly desirable. 
 
Drugs used for heart rate control: 
 
Oral β-blockers and Ivabradine, which is funny channel blocker are drugs that are 
commonly used to control heart rate(17). It is important to ensure that there are no 
contraindications to heart rate controlling drugs such as heart block, severe aortic stenosis 
or asthma. When β-blockers are contraindicated, nondihydropyridine calcium channel 
blockers may be used. 
 
Vasodilatation and anxiolytic methods: 
 
Sublingual nitroglycerine or nitroglycerine spray is used just prior to scanning will cause 
coronary vasodilatation and thereby increase visualization of all branches including the 
septal branches and relieve any non-fixed abnormality like coronary spasm. This increases 
the overall diagnostic quality of the study. Patients should be well hydrated prior to study 
to avoid sudden hypotension or arrhythmias during the study due to the effect of above 
mentioned drugs. Heart rate as well as blood pressures need to be monitored prior to the 
study.    
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An anxiolytic drug such as midazolam or lorazepam will calm the patient and prevent 
sudden rise or irregularity in heart rates at the time of scan. Rehearsal of breathing 
instructions prior to the scan is advantageous as it improves patient compliance, reduces 
anxiety and as a result reduces motion artefacts. It also helps in identifying any heart rate 
irregularities that may develop on breath holding(17). 
 
Safety aspects of patient medication: 
 
All medications are administered by trained nursing staff under the supervision of a doctor. 
According to protocol for any imaging study requiring medication, blood pressure and 
heart rate prior to first dose of drug is measured, followed by after the study and at the time 
of discharge. Since this is an outpatient procedure, patients are observed for 30 min after 
the study to ensure that there are no adverse effects related to the medication or contrast 
administered.  
 
Contrast related preparation:  
 
Documentation of any allergies, asthma or hypersensitivity reaction and premedication 
with anti-allergic medication and prednisolone or IV hydrocortisone decreases the risk of 
allergies with contrast injection. Serum creatinine values need to be checked to ensure 
normal renal function. If renal function is borderline or compromised in patients planned 
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for a CCTA, caution with regard to use of contrast agents is necessary. Informed consent 
is obtained prior to contrast administration.  Intravenous access with a large bore IV 
cannula in the right cubital vein is preferred since contrast is injected at high flow rates of 
about 5ml/second.  
 
Patient positioning and ECG lead placement: 
 
Patient is positioned supine and usually feet first position in the scanner gantry. ECG leads 
(3 or 12 lead ECG) is connected ensuring good electrical contact. Using additional 
conductive gel and shaving the chest if very hairy are recommended to prevent lead 
detachment during scan acquisition.  
 
ECG gating: 
 
ECG gating during cardiac imaging is a method that uses information from 
electrocardiographic signal to time the cardiac cycle and hence enable selective acquisition 
of images at specific points in the cardiac cycle. Gating techniques help in improving 
temporal resolution and minimizing motion related imaging artifacts. Also, gating allows 
for reduction of radiation doses.  
Two approaches are commonly used for cardiac gating – Prospective and retrospective 
ECG gating. Cardiac motion is the least during diastole, when passive filling of the 
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ventricles takes place. So in prospective ECG gating, ECG signal is used to acquire data 
only during cardiac diastole, by generating X-rays and receiving projection data only 
during cardiac diastole. This reduces the total radiation dose to the patient. However, 
prospective ECG gating and triggering have its limitations. It is effective only for slower 
heart rate as it is sensitive to heart rate changes and arrhythmias. In order to overcome these 
limitations, retrospective gating is used. Retrospective gating allows faster coverage of the 
cardiac volume with improved z axis resolution. Imaging happens throughout the entire 
cardiac cycle. But this is at the expense of high radiation dose. Also, since the entire cardiac 
cycle is imaged, functional analysis can also be performed(18) (19). 
 
Scanning techniques and parameters: 
 
Collimation and gantry rotation: 
 
Since the anatomy to be imaged is minute and in continuous rapid motion, at CT coronary 
angiography, the universal rule is that regardless of the scanner used, the collimation 
chosen should be the thinnest possible and the gantry rotation time chosen should be the 
fastest possible. 
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Tube current and voltage: 
 
Tube current and voltage adjustment is patient specific so that the lowest possible tube 
current setting is used in keeping with the ALARA (as low as reasonably achievable) 
principle(16). Adjustments are made based on patient’s body habitus such that a diagnostic 
study is obtained. For example, when scanning a normal sized adult for suspected CAD, 
using a 64 slice CT scanner with 0.625mm collimation and 330msec gantry rotation a tube 
current of 400Mas, with pitch ranging from 0.20 to 0.43 depending on the heart rate is 
adequate. In thinner adults a lower kV can be used(16).  
 
Contrast: 
 
High vascular enhancement is required to visualize the coronary arteries and their branches. 
Therefore, a high concentration of intravenous iodine containing nonionic contrast media 
with a fast injection rate (5ml/sec) is used. A saline chaser is used to prolong the plateau 
phase of contrast enhancement and also reduce streak artefacts as when present they can 
simulate stenosis of the RCA and result in its improper evaluation.(16) Individual scan 
delay time is determined by using a test bolus or by automated attenuation based triggering 
at a predetermined attenuation within the ascending aorta. The total amount of contrast 
including the test bolus used for a CT coronary angiography study ranges from 80 -115ml 
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Radiation dose optimization: 
 
Applying the ALARA principle is crucial in radiation safety and dose optimization. 
Prospective ECG gating should be used where possible. In cases were retrospective 
gating is required, ECG gated dose modulation technique should be used to reduce 
radiation. Scan range and scan protocols should be tailored to each patient. Scan range 
should be set inferior to shoulders. This prevents the automated prescribed mAs being set 
for the width of the shoulders instead of the thorax. Scan protocols are planned based on 
the patient’s weight or BMI. For smaller patients, as discussed earlier, tube voltage 
should be reduced to 100 kVp with corresponding increase in tube current to account for 
the increase in image noise.  For each patient, displayed predicted computed tomography 
dosage indicator vol (CTDIvol) and the displayed dose length product should be 
documented and reviewed at time of reporting(17).  
 
Image reconstruction and post processing: 
 
CT coronary angiogram studies are acquired as sub millimeter ECG gated data sets which 
can be reconstructed and displayed in various imaging formats for diagnostic purposes. 
Dedicated workstations that allow 2D and 3D reconstructions and reformation such as 
multiplanar reformation(MPR), maximum intensity projection(MIP), curved multiplanar 
reformation(cMPR) and volume rendering techniques(VRT) should be available for use. 
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Various workstation have been developed by providers such as GE, Terarecon, Toshiba to 
name a few.  
 
Raw data: 
 
Raw data consists of 2 dimensional images which are stacked in the cranio-caudal direction 
or the z axis as they were acquired. Scrolling through the slices displays the coronary and 
cardiac anatomy with minimum distortion or errors related to post processing. The main 
disadvantage of reading from a raw data set is that the reader has to mentally reconstruct 
in 3 dimensions the arteries and its anatomical relation with other structures in the 
thorax(20). 
 
Optimal window choosing: 
 
 Window level and window width needs to be adjusted for accurate interpretation. This is 
crucial to differentiate calcified plaque from normal contrast containing lumen and to 
distinguish intramural non calcified plaque from interstitium. Ideal window level should 
be at the mean of HU values within the region of interest, and 2.5 times the window level 
should be the corresponding window width(20). The reader often will have to make 
readjustments of window width and level, though a useful starting point for initial use is a 
window width of 800 and a window level of 300. 
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In order to assess cardiac morphology, the phase with minimum cardiac motion is selected. 
Relative percentage based approach of determining the point in the cardiac cycle is widely 
practiced. This means that the cardiac cycle is divided into 20 image sets reconstructed at 
different R -R positions in 5% increments or as 10 image sets in 10% increments (0% -
95% RR interval). The 60% R-R position yields good diagnostic quality images of the 
coronary in most patients. However, different R-R positions can be chosen for RCA and 
LCA based on their least motion(16). 
  
 
Image reconstruction parameters 
 
Field of view:  
 
In order to maximize spatial resolution, it is essential that the smallest possible field of 
view that covers the entire anatomy of the heart is chosen. In addition, often full field of 
view of the chest is acquired along the z plane in lung algorithm to look for concurrent lung 
abnormalities. When the indication for scanning is triple rule out, specifically tailored 
protocols are used to include vascular phase of aorta and the pulmonary arteries.  
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Reconstruction kernel: 
 
Kernels are dedicated reconstruction filters used for CT angiography. They help in 
providing a degree of edge enhancement to enable better visualization of smaller vascular 
detail by improving spatial resolution. They suppress image noise and thereby improve 
visual impression and contrast resolution between vessel wall and myocardium(16).  
 
 
 
 
 
 
 
 
Figure 6: Planning scanogram prior to CTCA, with ECG leads connected for ECG gating. 
Blue box indicates the area to be scanned 
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Interpretation formats:  
 
Calcium scoring: 
 
Calcium scoring involves a preliminary non contrast examination to look for calcification 
of the coronary arteries as well as the valves and pericardial surfaces. Dedicated computer 
software programs are supplied by vendors which recognize pixels above 130 HU in a non-
contrast study, as levels corresponding to calcium. The reader identifies each discrete 
calcific focus in the respective vessel distribution. A summed score for each vessel and for 
the total study (sum of all vessels) is calculated based on an area-density scoring system 
(Agatston) or volumetric measurement of each calcific focus(20). Calcium score in aorta, 
aortic valve, mitral valve and annulus, myocardium and pericardium is separately 
mentioned. 
 
Multiplanar reconstruction(MPR):  
 
MPR is the most commonly used alternative reconstruction format. It reconstructs planar 
images at any angular section through the acquisition plane. This allows visualization of 
the coronaries in the axial, orthogonal and oblique planes that are along the course of the 
arteries in the thorax. The result of these reconstructions are images that are similar to the 
familiar invasive angiography views. Usually, for MPR reconstruction, the thinnest 
available slice width is used. Workstations allow rotation of vessel on its longitudinal axis 
for 360 degrees or also scroll through transverse cuts through the length of the vessel 
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(Figure 7). These techniques help in identifying plaque, assessing its morphology and 
effect on the lumen and the adjacent vessel wall.  Curved MPR format produces the entire 
course of the vessel in one image (Figure 9). For accurate interpretation, the centerline of 
the vessel needs to be tracked correctly, else can cause artefactual lesions. Advantage is 
that longer course of vessels, especially if they are tortuous with change in direction can 
be followed and visualized 
 
Figure 7:Example of workstation interface which allows multiplanar imaging 
 27 
 
Figure 8: Basic reconstruction in the 3 standard imaging planes 
 
 
Maximum intensity projection (MIP): 
 
 
MIP and MPR though similar in the fact that various orthogonal and oblique views can be 
assessed, MIP is reconstructed in thicker sections to include the entire volume of the vessel 
and wall diameter (commonly used thickness for interpretation is 5mm) (Figure 10B). 
Longer segment of vessel is viewed with reduction in noise. But there is lack of detail 
regarding lesion or its attenuation characteristics.  Therefore, MIP is never used as the sole 
technique for interpretation.  
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Volume rendering technique (VRT): 
 
Commonly used technique that creates volumetric 3 dimensional representations of the 
cardia or coronary vasculature with an illusion of spatial integrity and color (Figure 10A). 
Spatial relationships are well demonstrated but this technique has limited use in the 
evaluation of coronary artery disease. Window settings and computer algorithms can affect 
apparent thickness of vessels. It is of better use in visualizing coronary anomalies, presence 
and position of bypass grafts and for patient illustration, education and counselling(20).  
 
    Figure 9, A- F: Curved MPR images of the coronaries allow visualization of the  
    entire tortuous course of the arteries in one image 
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Figure 10:  A-  volume rendered reformation of the aortic root and the coronaries; 
B – Maximum intensity projection (MIP) images of the aortic root and the coronary 
arteries 
 
 
 
Coronary artery anatomy: 
 
The heart is supplied by two main coronary arteries namely the right coronary artery and 
the left main coronary artery. These arteries arise from the aorta and it receives 5% of the 
total cardiac output.  
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Figure 11: Diagrammatic representation of the coronaries arteries and their    
branches. Image courtesy: www.meddean.luc.edu 
 
Left main coronary artery (LMCA): 
 
The LMCA arises from the left sinus of Valsalva, near the sinotubular ridge in the region 
of the left coronary cusp. Its length is variable, ranging from 10-15mm and it divides into 
the left circumflex artery (LCx) and the left anterior descending artery (LAD). Sometimes 
the left main coronary artery trifurcates into three branches, the third branch called the 
ramus intermedius (RI) arising between the LAD and LCx. This variation can be seen in 
15% of the normal population. The RI branch course laterally along the free wall of the left 
ventricle, similar to the course of diagonal branch of the LAD artery.   
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Left anterior descending artery (LAD): 
 
The LAD courses through the anterior interventricular groove up to the apex of the left 
ventricle. It lies in the epicardial fat and gives off multiple septal perforating branches 
which course medially and supply the anterior part of the interventricular septum, 
atrioventricular bundle as well as proximal bundle branch and diagonal branches which 
course laterally and supply the anterior free wall of the left ventricle.  
The first diagonal branch (D1) denotes the distinction between proximal and mid portion 
of LAD. More than one diagonal branch may be seen.  
 
Left circumflex artery (LCx): 
 
The LCx is located in the left atrio-ventricular groove and supplies the lateral wall of left 
ventricle through vessels which branch off with an obtuse angle. They are hence known as 
obtuse marginals or also referred to as lateral marginals. They supply the lateral margin of 
the left ventricle and a variable portion of the anterolateral papillary muscle. In about 10 to 
20% of the population, left dominant circulation is seen in which case the left circumflex 
artery supplies the posterior descending coronary artery. 
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Right coronary artery(RCA): 
 
The RCA arises from the right coronary sinus of Valsalva and traverses the right atrio-
ventricular groove towards the crux of the heart. The first branch in 50-60% cases is a small 
conus branch which supplies the RV outflow tract. In few cases (30- 35%) the conus artery 
arises from the aorta. In 60% cases, a sinus node artery arises as the second branch of RCA 
which runs posteriorly to the sino-atrial node (in the rest of the 40%, it originates from the 
circumflex artery).  
The next branches are marginal branches which supply the anterior wall of right ventricle. 
The largest of these branches is called the acute marginal branch (AM). It comes off at an 
acute angle and supplies the anterior wall of right ventricle. The RCA continues down to 
give off a branch to the AV node. 70 to 80 % of the population has right dominant 
circulation in which the right coronary artery gives off the posterior descending artery 
which supplies the inferior wall of the left ventricle and inferior part of the septum. 
 
Dominance: 
 
The artery which is referred to as dominant is the artery which gives rise to the posterior 
descending artery (PDA) and the posterolateral branch (PLB). In 70% of cases, RCA is 
dominant. In 10% of cases, LCA is dominant with the LCx giving rise to the PDA and 
PLB. The remaining cases have a co dominant system with portions of the diaphragmatic 
LV wall being supplied by both RCA and LCx.  
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Segmental coronary artery anatomy: 
 
Conventional coronary angiography uses a classification system that divided coronary 
arteries into 18 segments(21). In 1975, the segmentation model was proposed by ‘The 
American Heart Association’ (AHA). This segmentation is based on anatomic structures 
which act as standard landmarks.  
A similar system is used in CTCA as well in order to maintain uniformity of 
nomenclature to aid better communication among physicians and reproducibility.  
Figure 12: SCCT Coronary Segmentation Diagram 
 
Axial coronary anatomy definitions derived, adopted, and adjusted from WG Austen, JE Edwards, RL 
Frye, GG Gensini, VL Gott, LS Griffith, DC McGoon, ML Murphy, BB Roe: A reporting system on 
patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary 
Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51:5–
40.  
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Schematic representation (figure 12) of the same have been released for use and reference 
by the society of cardiovascular computed tomography (SCCT)(21). The segmentation is 
described in detail in Table 1. 
Table 1:  Segmentation model of coronary arteries 
Adapted from Society of Cardiovascular Computed Tomography published guidelines for interpretation 
and reporting of coronary CT angiography, 2010 
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Normal coronary artery diameter: 
 
Normal coronary artery diameter has not been established with MDCT.  
Focal aneurysms are defined by focal abnormal dilatation of more than 1.5 times the 
diameter of the adjacent coronary artery. When the coronary artery is diffusely dilated it is 
called as ectatic.  
 
Analysis of coronary artery pathology: 
 
Coronary arteries are initially studied for anomalies in the course of branching of the main 
coronary vessels. Any variations in their relationship to the major cardiac structures also 
need to be noted.  
 
Coronary artery lumen and wall imaging:  
 
Pathologies affecting the lumen such as focal plaque or diffuse narrowing, wall irregularity, 
aneurysm or ectasia need to be looked for. Overall caliber and contour of the lumen with 
variations in density within the vessel wall and intraluminal portion of the coronary artery 
need to be noted. Intraluminal plaque when present, is localized based on its segmental 
position as per the AHA segmentation model. Plaque characteristics are described as non-
calcific with lipid or fibrous component or calcified based on its CT attenuation values 
(discussed later). 
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Assessment of burden of coronary artery disease: 
 
Calcium score (CACS): 
 
Arthur Agatston and his colleagues introduced the quantitative CACS protocol in 
1990(22). This remains the standard method in calcium scoring. Any structure with 
densities of 130 Hounsfield units (HU) or more and of an area of 1mm2 or more is 
segmented as a calcified focus (Figure 13). The calcified foci that overly the anatomic sites 
of coronary arteries are considered to represent calcified plaques. They are given stratified 
density scores 1, 2, 3 and 4 which represent the densities 130-199 HU, 200-299 HU, 300-
399 HU and ≥ 400 HU, respectively. 
 
 
 
 
 
 
 
Figure 13: (A, B): Segmentation of calcium on non-contrast CT by identification of any  
structure with densities of 130 Hounsfield units (HU) or more and of an area of 1mm2   
 
 
A B 
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The total Agatston score (AS) of each individual is calculated by summing the scores of 
every calcified focus through all of the coronary arteries(21). Coronary artery calcium 
scoring has been established as a strong tool for prediction of coronary events, reflecting 
the burden of coronary artery disease. Calcium scoring is considered the “gatekeeper” for 
CCTA.  
 
Contrast enhanced CT in determining atherosclerotic burden: 
 
Contrast enhanced CT of the coronary arteries provide further information with regards to 
presence of calcified and non-calcified plaques and the degree of stenosis, thereby arriving 
at an accurate estimation of the burden of atherosclerotic disease.  
Apart from calcium scoring, various other scores have been developed to grade the amount 
of plaque and resultant stenosis. Johnson et al used a scoring system which utilizes 4 
parameters to grade the burden of coronary artery disease(23). These are: 
1. Segment involvement score 
2. Segment plaque score 
3. Segment stenosis score 
4. Modified Duke’s prognostic index  
Each of the coronary artery segments are scored based on the presence of plaque and degree 
of stenosis. Sum of the scores of each segment gives the final scores for that particular 
patient(23). 
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Segment involvement score (SIS): 
 
A segment of the coronary artery is scored as involved if there is plaque. Each segment is 
scored according to the its involvement as absent or trace or as present (Figure 14). Absent 
/ trace plaque is scored as 0 and presence of plaque is scored as 1.  
  
 
 
Figure 14: Diagrammatic representation of estimation of segment involvement score 
 
Segment plaque score (SPS): 
 
The segment plaque score is an indicator of plaque burden. For each segment, the amount 
(volume) of plaque, whether calcified or not is scored as none or trace (0), mild (1), 
moderate (2), or heavy (3). When there are multiple lesions in a given segment, the segment 
is scored as a whole. The SPS for each patient is calculated as the sum of individual 
segments’ burdens(23). 
Figure 15: Diagrammatic representation of estimation of segment plaque score 
 
Plaque Score 
(SIS) 
Absent / trace 0 
Present  1 Segment 1 Segment 2 Segment 3 
SIS - 0 SIS - 1 SIS - 0 
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Segment stenosis score (SSS): 
 
Segment stenosis score estimates the diameter of stenosis caused by the plaque. It is scored 
as very mild < 30%, mild 30-50%, moderate 50-69%, or severe >=70%, scored as 0, 1, 2, 
and 3 respectively. The sum of the individual segments is calculated as the segment stenosis 
score(23) 
 
 
 
 
Figure 16: Diagrammatic representation of estimation of segment stenosis score 
 
 
 
Modified Duke’s prognostic index: 
 
This score is derived from conventional angiography and modified to suit computed 
tomography coronary angiography. The Duke’s prognostic index is shown to correlate with 
cardiac mortality. With a higher Duke’s score, the risk of cardiac mortality increases(23). 
The modified Duke’s prognostic index criteria has been described in Table 2. 
Percentage stenosis  Score 
Very mild (<30%) 0 
Mild (30 -50%) 1 
Moderate (50-69%) 2 
Severe (>=70%) 3 
Segment 1 Segment 2 Segment 3 
SSS - 0 SSS - 3 SSS - 1 
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Table 2: Modified Duke's prognostic criteria 
 
 
Plaque characteristics 
 
Plaques in the coronary arteries due to atherosclerosis are primarily asymmetrical focal 
areas of intimal thickening. The result from accumulation of various components such as 
foamy macrophages, smooth muscle, necrotic debris and calcium.  
Pathological studies have shown that components of plaque have an important role to play 
in the pathophysiology of coronary artery disease. Acute coronary syndromes which 
present with acute chest pain are often result of plaque rupture(24). Plaque rupture is related 
to high percentage of intra-plaque lipid core within non-calcified plaques. 
  
 41 
 
Therefore, the imaging not only identifies and delineates the plaque boundaries but also 
helps to identify the various components within the plaque such as lipid, fibrous tissue and 
calcium. 
 
Figure 17:Diagrammatic represent of different plaque characteristics within vessel lumen 
that help classify them as lipid, fibrous, mixed and calcified plaque. 
 
Intravascular  ultrasound and optical coherence tomography have been shown to provide 
most accurate information regarding plaque morphology that matches the findings on 
histopathology(25)(26). The use of these modalities are however limited due to the 
invasiveness, limited availability and high cost.  
Therefore, less invasive modalities like CT and MRI play a more important role in plaque 
characterization, especially among patients with low or intermediate risk of coronary artery 
disease where imaging is more of a screening tool(27).  
Researchers since the early days of CCTA identified the ability of CT to depict attenuation 
differences within an atherosclerotic plaque. This therefore helps to differentiate plaques 
as lipid rich, fibrous and calcific(28).  
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With rapid development in CT technology, characterization as well as quantification of 
plaque is now possible. Good correlation between plaque classification on CT as compared 
to IVUS has been observed (29) (30).  
 
Figure 18A & B: Representation of grey scale and colour mapping of coronary artery 
plaque based on CT Hounsfield units 
 
Different vendors provide software that are capable of automatic plaque segmentation, 
differentiation of plaque components using various attenuation thresholds and also 
provides color maps of plaque composition(31).  
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Attenuation value limits to identify various components of plaque can be customized and 
predefined. The ranges for different components are <30HU for lipid plaque, 30-149HU 
for fibrous plaque and >150HU for calcific plaque(32) 
Available software provides automated, semi-automated plaque identification and manual 
quantification methods. Segmentation is performed on curved multiplanar reformatted 
images of the respective coronary artery. Completely automated software identify plaque 
and quantify them based on predefined HU values. This can be technically difficult and 
inaccurate due to variations in lumen attenuation, overlap in CT numbers of iodine and 
calcified plaque, and inherently low tissue contrast of CT(33).  
 
 
 
 
 
 
 
 
 
Figure 19: Colour mapping software Plaq ID segments various components of plaque and 
provides volume of each component 
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To overcome this softwares offer semi-automated and manual modes. These allow manual 
adjustment in case of obvious divergence from the outer limit of the vessel wall by the 
semi-automatic segmentation of vessel edge(31). The outer wall and the lumen can be 
manually defined. This process is however time consuming and observer dependent. 
Overall, studies have shown that manual plaque quantification and automated systems 
provide similar results(33). Once the plaque is identified and marked out, based on 
predefined HU threshold levels, the plaque is segmented.  Plaque mapping software uses 
calibrated HU thresholds to automatically segment and measure volumes of vessel, lumen 
as well as low, medium and high density plaque components.  
 
Good agreement is observed between manual plaque quantification and IVUS(34). Plaques 
are primarily classified as calcified and non-calcified based on the presence of calcium 
(calcified plaque is defined by attenuation values more than 150HU and forming >50% of 
plaque volume). Motoyama et al. in their study classified non-calcified plaque as lipid 
plaques when mean CT density was <30HU and fibrous plaques when mean CT density 
values were 30-150HU(35) However, it should be emphasized that differentiation of non-
calcified plaque into lipid and fibrous plaques by using CT attenuation values is 
confounded by the significant overlap of attenuation values between the two types of 
plaque(35)(32)  
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Only 20% of the total atherosclerotic plaque burden is represented by calcified plaque. It 
is thought to be seen in advanced and late stages of atherosclerosis. Early atherosclerotic 
plaques are often non calcified.(36). The association between traditional risk factors and 
calcified plaque have been extensively studied. Recent study by Vergallo et al also 
explored the association between the Framingham Risk Score (FRS) and coronary plaque 
characteristics assessed by optical coherence tomography (OCT) imaging(37).  Further 
evidence on association of cardiovascular risk factors with vulnerable plaques is required 
to establish additional information on risk assessment using MDCT in this population of 
patients  (36).  
 
The purpose of this study is to evaluate the degree of correlation between the 
conventionally used risk models such as the Framingham risk score, along with the NCEP 
core risk score and the burden of coronary artery disease as assessed by various scores on 
coronary CT angiography 
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MATERIALS AND METHODOLOGY: 
 
Study period: 
 
The study was conducted in the Department of Radiology in the period between Jan 2015 
and May 2016 after obtaining approval from the Institutional Review Board (IRB Min No 
9197 (OBSERVE) DATED 8.12. 2014) 
 
Study design: Prospective cross sectional descriptive study  
 
Recruitment of subjects:   
 
Inclusion criteria:  
 
Consecutive patients with suspected coronary artery disease, who were advised to 
undergo coronary CT angiography in the period between Jan 2015 and May 2016 
and gave informed consent for the same, were included. 
  
Informed consent was taken by the principal investigator after ensuring that there 
was no contraindication for undergoing a CT coronary angiogram.  
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Exclusion criteria:  
 
1. Patients with contraindication to the administration of iodinated contrast. 
2. Previous history of myocardial infarction, stenting, coronary artery bypass graft 
stenting. 
3. Poor image quality resulting in suboptimal image analysis.  
4. Pregnancy 
5. If lipid profile of the patient was not readily available.  
 
Sampling strategy 
 
All consecutive patients with suspected coronary artery disease, who fulfilled the inclusion 
criteria, have none of the exclusion criteria, and have given consent to be a part of the study 
were included. 
 
Sample size calculation 
 
 Using a pilot retrospective review, a sample of 144 (72 cases and 72 controls)was arrived 
at to detect 20% difference in high risk (i.e. above 20% of Framingham risk score) among 
those with coronary artery disease and those without coronary artery disease, with a 
power of 80% and 5% type 1 error using two tailed chi square test, assuming that 30%  of 
patients are high risk group among those with coronary artery disease on CT angiogram 
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and 10% of patients are of high risk group in those with no coronary artery disease on CT 
angiogram 
 
Data collection 
 
Demographic details of the patient with history of risk factors, such as diabetes, 
hypertension, treatment for hypertension, dyslipidemia, smoking and positive family 
history was collected using a questionnaire which was part of the clinical research form 
(Annexure 2). Indication for referral was noted. Weight and height, systolic and diastolic 
blood pressure along with lipid profile values were also documented.  
 
Risk stratification of patients 
 
 Risk stratification of each patient according the NCEP core risk score was performed as 
diagrammed in Figure 20. Patients with diabetes directly fell into the high risk category as 
per this criteria. 
 Using risk calculators, with the above information collected, Framingham Risk Estimates 
(FRE) were calculated for each patient. This estimates the percentage risk of developing 
coronary artery disease in the next 10 years. Based on latest NCEP/ATP III guidelines 
along with calculated FRE, each patient was assigned a low, intermediate, moderately high 
or high risk category as per the following algorithm.   
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Figure 20: Risk scoring algorithm used to categorize study population 
 
Patients were classified as low risk if they had no or only 1 risk factor with any FRE, 
intermediate risk if they had 2 or more risk factors with <10% risk of coronary artery 
disease in 10 years, moderately high risk if they had 2 or more risk factors with 10-20% 
risk of coronary artery disease in 10 years and high risk if patients had 2 or more risk factors 
with more than 20% risk of coronary artery disease in 10 years. The high risk group also 
included patients with diabetes and peripheral vascular disease irrespective of their FRE 
and risk factor count.   
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Coronary CT angiography 
 
ECG gated coronary CT angiography was done in CT Room 22, using the GE Advantage 
750 HD 64 slice dual energy CT machine. Retrospective or prospective approach of ECG 
gating was decided based on the patient’s heart rate.  
For heart rates less than 60, prospective gating was used. Most patients were prescribed β-
blocking drugs or Ivabradine, to control heart rate. If patient’s heart rate was more than 72 
beats per minute (bpm) at the time of scan, injection Metaprolol was given IV on table just 
before the scan. 
 Heart rate, blood pressure and ECG were monitored. 2 puffs of nitroglycerin spray was 
given on table before beginning image acquisition. 1mg midazolam diluted in 1ml NS prior 
to commencement of calcium scoring was given intravenously in case of anxiety related to 
the test. 
ECG gated unenhanced scan from the level of the carina to the diaphragm was acquired 
for calcium scoring followed by contrast enhanced angiogram of the coronary arteries. In 
order to time the commencement of the contrast enhanced scan, bolus tracking was done 
with the ROI in the ascending aorta. Nonionic iodinated contrast was injected by a 
pressure injector at the rate of 5ml/sec(80-100ml of contrast) followed by a saline chaser 
also at 5ml/sec(~40ml of saline) .  
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Images were acquired using collimation of 0.6 mm, slice acquisition 64 × 0.6 mm using 
the z-flying focal spot technique, gantry rotation time 330 ms, pitch 0.20–0.43 adapted to 
heart rate, tube voltage 80 - 120 kV (depending on body habitus) and maximum tube 
current 400 mAs per rotation  
 
Image reconstruction and post processing: 
 
The acquired images were reconstructed to reduce noise and improve spatial resolution in 
the thinnest possible slice thickness. In retrospective gating, optimal cardiac phase with 
minimal motion was chosen to analyze the right coronary artery and left coronary artery 
respectively.  
Curved multiplanar reformations, maximum intensity projections, volume rendered images 
were generated on dedicated workstations (AW Server, TeraRecon) for reporting.  
 
Image interpretation: 
 
The coronary CT angiography studies were interpreted by the principal investigator and 
checked by a radiologist of professor grade (guide and co-guides).   
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Steps in image interpretation: 
 
1. Calcium scoring was done using Smartscore, a semi-automated software provided 
by GE Healthcare. The total score obtained was graded as insignificant (<10AU), 
mild (10-100AU), moderate (101-400 AU) and severe (>400AU) 
Figure 21:Semiautomated calcium scoring software segments calcific foci (any 
focus>130HU) on unenhanced CT scans and provides a total score based on Agaston’s 
scoring 
 
2. Transverse/ axial image stack was scrolled through for an overview of the coronary 
artery anatomy and image quality. Also, identification of plaques on axial images 
was done 
3. MIP and MPR images were used to identify, demonstrate and study plaques in 
longitudinal and perpendicular planes. The presence of plaques on transverse 
images was confirmed. 
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4. In case of no obvious plaques, segment based analysis of the RCA, LAD and the 
LCx was done to avoid false negatives 
5. If plaque was found, or there is a point of coronary artery stenosis, in order to avoid 
false positives due to motion artifacts, it was essential that the plaque be identified 
on at least two reconstruction time points. 
 
6. The vessels involved by plaque were documented. 
 
7. Segment involvement scores(SIS): SIS was calculated for each segment, which 
basically denotes the number of segments affected by plaque. A segment was scored 
0 when there was absent and scored 1 for any amount of plaque present. The score 
of each segment was totaled to arrive at a total segment involvement score for the 
patient. The total SIS was further classified into grades of severity as zero if not 
involved, 1–2 as mild, 3–4 as moderate, and more than 4 as severe or heavy.  
 
8. Segment plaque score (SPS): For all plaques that were identified, the amount of 
plaque whether calcified or not was graded visually as none or trace (0), mild (1), 
moderate (2), or heavy (3).  The total score was obtained from a sum of individual 
segment scores. The total SPS was further classified into grades of severity as zero 
if no or trace plaque, 1–3 as mild, 4–7 as moderate, and 8 or more as heavy plaque 
burden.  
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Figure 22:Grading of segment plaque score (SPS) 
 
 
9. Segment stenosis score: For all identified plaques, the resultant luminal narrowing 
at that level was quantified by measuring the degree of stenosis. This was done by 
calculating the ratio of the diameter of residual lumen at the site of stenosis to a 
proximal or distal normal-appearing reference site.  
 
10. Degree of stenosis was measured using semi-automated softwares which allowed 
optional manual correction of boundaries of the lumen at the normal appearing 
reference site and at the point of maximum stenosis to arrive at an accurate 
quantification of stenosis.  
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11. The degree of stenosis was graded as very mild < 30%, mild 30-50%, moderate 50-
69%, or severe >=70%, scored as 0, 1, 2, and 3 respectively. The sum of the scores 
of each of the segments gave the total segment stenosis score. The total SSS was 
further classified into grades of severity as zero if no stenosis, 1–3 as mild, 4–7 as 
moderate, and 8 or more as severe. 
Figure 23: Grading of segment stenosis score 
 
12.  Modified Duke’s prognostic index: Based on the site and severity of the vessel 
involved and the number of measurable stenosis, each patient was placed under one 
of the 7 categories (Duke 0 – Duke 6) of the Modified Duke’s prognostic index. The 
Modified Duke’s prognostic index was further classified as Category 0 as 0, 
Category 1 a mild, Category 2 as moderate, and more than 2 as severe.  
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13. Each of the identified plaques were characterized using semi-automated software 
called PlaqID, offered by AW Server, GE Healthcare. The software segmented the 
plaques based on predefined fixed attenuation values (HU values). The fixed cut off 
values used were <30HU for lipid rich plaque, 30-150HU for fibrous plaque and 
>150HU for calcified plaque. various components of the plaque was identified and 
their volumes were quantified. 
 
 Based on the quantified volumes, classification of plaques into non calcified, mixed 
and calcified was done.  
 
A plaque was defined as non-calcified when it was of lower attenuation than the 
luminal contrast with HU values of less than 150HU and no calcification. A plaque 
with calcification was classified as calcified plaque when more than 50% of the 
plaque volume was calcium. A plaque with both calcified and non-calcified content 
was defined as mixed plaque when the volume of calcium was less than 50% of the 
total plaque volume.   
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Figure 24: Example of semi-automated plaque segmentation. 
69-year-old lady with atypical chest pain and inconclusive TMT, underwent CT coronary 
angiography for evaluation of cardiac status with the following findings. The curved MPR 
of the LAD showed an eccentric calcified plaque in the proximal LAD (yellow – calcium, 
green – lumen). The plaque has been auto segmented based on attenuation values by PlaqID 
software on AW server provided by GE Healthcare. The outline of the plaque and the 
residual lumen is verified on the axial view of the LAD obtained from the curved MPR 
images. 
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SUMMARY OF METHODOLOGY 
Figure 25:Flow chart shows summary of methodology of recruitment, risk stratification 
and coronary CTA interpretation 
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Statistical analysis 
 
Data entry was performed using Epidata Entry version 3.1, a dedicated data entry software. 
Statistical analysis was performed using SPSS version 20.0 software. A p value of less than 
0.05 indicated statistical significance. 
• Discrete variables are reported as proportions. 
• Continuous variables are reported as Mean ± SD or median and interquartile range. 
• ROC curve analysis was done to demonstrate the predictive value of Framingham 
risk estimate to identify coronary artery disease. 
• A second model for ROC curve analysis was performed using both FRE and calcium 
score to study the predictive value of combined FRE and calcium score for CAD.  
• Pearson’s correlation test was used to analyze the correlation between Framingham 
risk estimates and each of the plaque burden scores.  
• In order to demonstrate the association between the four NCEP risk categories and 
plaque burden scores, contingency tables were generated. 
• Pearson’s chi-square goodness of fit test was used to analyze the correlation 
between NCEP risk categories and plaque burden scores. 
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RESULTS AND ANALYSIS  
 
Figure 26:STROBE flow chart representing recruitment process for study. 
 
A total of 144 patients with suspected coronary artery disease participated in the CT 
coronary angiography study. 
 
Baseline patient characteristics:  
 
1. Age distribution:  
 
The mean age of patients included in the study was 50 years.  
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2. Gender:  
 
43% (63) of the patients were men and 55% (81) of the patients were women  
 
 
 
 
 
                  Figure 27: Gender distribution among study population 
 
3. Indication for referral for CCTA: 
CCTA was performed in the study population for the following specific 
indications (Figure 28) 
Figure 28: Various reasons for referral of patients for CCTA 
Men 
44%
Women 
56%
Patient profile
Men Women
Atypical chest 
pain
53%
Inconclusive 
treadmill
12%
Family 
history
1%
Several risk 
factors like 
HTN, DM
10%
Properative 
clearance
2%
Patient anxiety
1%
Others
21%
Indication for referal for CCTA
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The most common indication for referral for CTCA was atypical chest pain and 
inconclusive treadmill test results. Other miscellaneous indications like for coronary 
CT angiography such as dyspnea on exertion, false positive thallium studies, 
ischemia on SPECT formed the other significant proportion of cases referred.  
 
 
4.  Risk profile: 
 
The most prevalent risk factor among the study population was hypertension and 
dyslipidemia. The least prevalent risk factor was positive family history and 
smoking. 
 
 Table 3: Risk factor profile among the study population 
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Parameters of risk stratification 
The risk scoring systems used in the study were the Framingham risk scoring system and 
the NCEP risk categories.  
 
1. Framingham risk estimate: 
 
The median 10 year Framingham risk estimate (FRE) was 5.8% with an interquartile 
range of 3 – 12 
 
2. NCEP core risk categorization:  
 
Risk stratification of the study population based on FRE and NCEP risk categories 
revealed that approximately half the study population (54%, n=77) of the patients 
fell into the low risk category and approximately one- fourths of the study 
population fell into the high risk category (26%, n= 38)  
    Figure 29:Distribution of risk categories among the study population    
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Findings on coronary CT angiogram  
 
1. Presence of coronary artery plaque: 
 
Out of the 144 patients who underwent coronary CT angiography, coronary artery 
disease was present only in 22% of patients (n=31). The rest of the 113 patients had 
no coronary artery plaque.   
 
Figure 30: Prevalence of coronary artery plaque in study population 
 
 
2. Predictive potential of Framingham risk estimate (FRE): 
 
ROC curve analysis was done to test the potential of Framingham risk estimate to 
predict the presence of subclinical atheroma. Figure 31 indicates that FRE is a good 
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Presence of coronary artery plaque 
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indicator of the presence of coronary artery plaque. The area under the curve was 
0.80 (95% CI: 0.71- 0.88, p <0.001).  
: Figure 31: Predictive potential of FRE for coronary artery plaque – ROC curve analysis 
 
3. Arteries involved by plaque 
 
Among patients with coronary artery plaque (n=31), the left anterior descending 
artery (LAD) was the most commonly involved vessel (80.6%) followed by the right 
coronary artery (51.6%).  
 
 
 
Area under curve 95% C.I. 
0.801   0.71- 0.88 
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Table 4: Distribution of atherosclerotic plaque in the coronary arteries among 
patients with coronary artery disease 
 
4. Risk categories among patients with coronary artery plaque 
51% of patients with coronary artery plaque were belonged to the high risk category. 
Most of these patients had diabetes and hence were categorized into high risk 
category. (9 out of 14 patients in the high risk category).  
Figure 32: Distribution of risk categories among patients with coronary artery plaque 
on CCTA 
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5. Calcium scoring (CACS):   
 
a. Of the 144 patients who underwent a CCTA as part of the study, as shown in 
figure 33, on the non-contrast CT, majority of them (78%, n=113) did not have 
any coronary calcification (calcium score=zero).  
 
 
 
 
 
 
Figure 33: Distribution of calcium score among study population 
 
6. Risk categories versus calcium scoring: 
 
i. Among patients with calcium score of zero, 62% belonged to the low risk 
category and 20% to the high risk category (Figure 34).  
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Figure 34: Distribution of risk categories among patients with CACS of zero 
 
ii. Among the 31 patients with calcium score of more than zero, the distribution of 
risk categories is as follows: 
Table 5: Distribution of calcium score among various risk categories 
 
None of the patients with low risk scores had severely high calcium scores. High calcium 
scores were seen in patients with both high risk and those patients with intermediate risk. 
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7. Potential of combined Framingham risk estimate and coronary calcium score 
to predict coronary artery disease: 
Figure 35: ROC of Framingham risk estimate(FRE), calcium score (CACS) 
and FRS combined CACS to predict coronary artery disease 
 
Table 6: The area under curve of the possible coronary artery disease predictors 
 
These results show that by FRE when combined along with calcium score 
is a superior indicator than using FRE or calcium score as a sole indicator 
to predict the presence of coronary artery disease.  
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8. Coronary artery plaque burden  
 
a. Out of the total of 144 patients recruited, 31 patients (22%) had atherosclerotic 
plaque.  
 
Plaque burden as assessed by each of the four CT scores was categorized into 0, mild, 
moderate and severe. Their distribution within the study population has been 
represented in Table 7.   
Major proportion of patients had a score of zero across all different plaque burden 
scoring systems.  
 
Table 7: Distribution of study population across the grades of severity of atherosclerotic 
disease burden assessed by the four CT scores  
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Association of conventional risk scoring models and coronary artery plaque 
 
1. Correlation between Framingham risk estimate and plaque burden scores: 
 
There was moderate positive correlation between Framingham 10-year risk estimate 
and the various CT scores assessing atherosclerotic plaque burden (all, p value 
<0.001) as elaborated in Table 8.  
 
Table 8: Correlation between Framingham 10-year risk estimates and atherosclerotic 
plaque burden scores as assessed by CCTA 
 
 
Pearson’s correlation co-efficient for each of the plaque burden scores fall 
between 0.3-0.5, suggestive of moderate positive correlation.  
The results have been graphically represented using scatter plots (Figure 36). This 
shows moderate correlation between the Framingham risk estimates and each of 
the plaque burden scores.  
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Figure 36: Correlation between Framingham risk estimate and the four plaque burden 
scores; A - FRE versus SIS, B - FRE versus SPS; C- FRE versus SSS; D- FRE versus 
Modified Duke’s prognostic index 
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2. NCEP risk categories versus plaque burden scores:  
 
Contingency tables generated between NCEP risk categories and various plaque 
burden scores showed an association between the two variables (X 2 (9) = 20.1, 24.9, 
34.1, 26.2 for SIS, SPS, SSS and Modified Duke’s prognostic index respectively; all 
p<00.1) (Table 9).  
Table 9: NCEP risk categories versus four measures of coronary plaque burden 
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a. NCEP risk categories versus Segment Involvement Score (SIS): 
 
Though there were patients from all 4 risk categories who had segment involvement 
score of 0, the greater proportion (89.6%) of patients belonged to the low risk 
category  
Figure 37: Comparison of NCEP risk categories with segment involvement scores (SIS); 
NCEP versus SIS in all patients recruited in study; n=144 
 
Among those with coronary artery disease on CCTA, 38% with mild SIS, 50% of 
patients with moderate SIS and 50% of patients with heavy SIS belonged to the high 
risk category. Therefore, patients with higher risk showed involvement of more 
number of segments.  
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Figure 38: Comparison of NCEP risk categories with segment involvement scores in 
patients with coronary artery disease 
 
 
b. NCEP risk categories versus Segment Plaque Score (SPS): 
 
92% patients in the NCEP low risk category had zero segment plaque score. None 
of the patients in the low risk category had a heavy plaque and only one patient from 
the low risk category had moderate plaque burden. Therefore, overall, good 
correlation was seen between NCEP low risk category and low plaque burden 
assessed by segment plaque score (SPS) (Figure 39).  
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Figure 39: NCEP risk categories compared with segment plaque (SPS) among all     patients 
recruited in study; n=144 
 
 
Analysis of SPS among the subset of patients with coronary artery plaque on CCTA 
showed that patients who had heavy plaque (SPS score >8) fell into matching NCEP high 
risk category. 60% of patients who fell into the intermediate risk category had moderate 
plaque burden. 20% of the remaining patients had heavy disease and 20% of them has 
insignificant plaque burden. Overall, there is poor correlation between intermediate NCEP 
risk category and coronary artery plaque burden as assessed by SPS.  
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Figure 40: NCEP risk categories compared with segment plaque scores (SPS) in     patients 
with coronary artery disease; n= 31 
 
 
c. NCEP risk categories versus Segment Stenosis Score (SSS): 
 
Segment Stenosis Score may not correlate with segment plaque score because an 
eccentric moderate plaque may not cause significant stenosis.  
Among 144 patients, only 12 patients had plaque that caused quantifiable stenosis 
of the coronary artery ranging from mild stenosis (30-50%) to severe stenosis 
(>70%).  
97% patients in the low risk category had a SSS of zero. 3% of them had SSS of 1-
3 which was classified as mild. None of them had moderate or severe stenosis and 
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this suggests that there is good correlation between NCEP category and segment 
stenosis score in the low risk group.  
Figure 41:NCEP risk categories compared with segment stenosis scores (SSS) in all 
patients recruited in study; n=144 
 
 
Stenosis less than 30% was considered as insignificant and given a score of zero. So, out 
of 31 patients with coronary artery disease, 16 patients (~50%) had less than 30% stenosis. 
Significant stenosis of more than 70% was seen only among patients belonging to the high 
risk category, suggestive of good correlation between high NCEP risk category and 
coronary artery plaque burden quantified using segment stenosis score.  
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Figure 42:NCEP risk categories compared with segment stenosis scores (SSS) in patients 
with coronary artery disease; n=31 
 
d. NCEP risk categories versus Modified Duke’s Prognostic Index: 
 
Patients falling into Duke category 3 and above were classified as heavy due to the 
presence of at least 2 moderate stenosis. 81% (117 out of 144 patients) of patients were 
categorized into Duke category 0 as they had no plaque or insignificant trace amounts 
of plaque. Among patients in Duke 0 category, 60% of patients belonged to the NCEP 
low risk category.  
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Figure 43:NCEP risk categories compared with Modified Duke’s Prognostic index (MDPI) 
in all patients recruited in study; n=144 
 
 
Similar to SPS, 60% of patients with Duke category score of more than 3 (2 or more 
moderate stenosis) belonged to the high risk group. The remaining 40% patients belonged 
to the intermediate group. But no patient with low risk had a Modified Duke’s index of 
more than 3, thereby suggestive of good correlation between NCEP low risk group and 
Modified Duke’s prognostic index. Hence, it demonstrates the low likelihood of patients 
in the low risk group from developing a cardiac event in the next 5 years.  
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Figure 44: NCEP risk categories compared with Modified Duke’s Prognostic index 
(MDPI) in patients with coronary artery disease; n=31 
 
 
Plaque characterization using CCTA:  
 
a. Distribution of plaques among study population: 
 
Of 2592 segments studied, 79 segments (4%) had evidence of plaque. The remaining 
2513 segments (96%) had no plaque.  
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Of the 79 segments involved, 62 segments had calcified plaques, 14 segments had 
mixed plaque and 3 segments had non calcified plaque.  
Figure 45:Distribution of subtypes of coronary artery plaque in the study population 
 
b. NCEP risk categories and plaque type 
 
Comparison of the NCEP risk category versus type of plaque present in a segment revealed 
the presence of calcified plaque across all risk groups. Mixed plaque was also seen across 
all risk groups in similar proportions (17-24%). Non calcified plaque, which is considered 
the most vulnerable for plaque rupture or thrombosis, resulting in a coronary event was 
seen only in 3(4%) of the 79 segments involved. All segments with non-calcified plaque 
were of patients in the intermediate risk group (Figure 46).  
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Figure 46: NCEP risk categories versus prevalence of plaque subtypes 
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SUMMARY OF RESULTS 
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DISCUSSION: 
 
In this cross sectional study of 144 patients who underwent coronary CT 
angiography (CCTA) for suspected coronary artery disease, the percentage of patients who 
fell in the NCEP low, intermediate, moderately high and high risk categories were 54, 12, 
8 and 26% respectively.  
This study found a trend towards good correlation in the Indian population between 
Framingham risk estimates and presence of coronary artery plaque on CCTA (AUC of 
0.801, 95% CT 0.71- 0.88, p<0.001).  
This is of value in the background of the disagreement that exists regarding the predictive 
value of conventional risk models like the Framingham risk estimate (FRE) and the NCEP 
risk categories in the prediction of the risk of developing a future coronary disease event 
(23). FRE and NCEP risk categories are epidemiological tools which were developed for 
assessing risks in populations and are considered to have limited value in risk prediction 
when applied to individual patients(38). Therefore, a good correlation between 
conventional risk scores and coronary artery disease burden on CCTA validates use of 
these conventional scoring systems as the starting point in the management of patients 
especially with respect to primary prevention strategies.  
We found that calcium scoring performed using the algorithm developed by 
Agatston et al correlated with risk categories as well as atherosclerotic plaque burden as 
assessed by CCTA. 62% patients with zero plaque belonged to the low risk category. 
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Higher calcium scores were seen in patients in the high risk category and they also had 
higher SIS, SPS, SSS and belonged to higher categories in Modified Duke’s prognostic 
index. It has been established that non contrast computed tomography for calcium scoring 
is robust in predicting plaque burden and has been used for risk stratification along with 
conventional risk scoring systems.  In our study, combined use of FRE and calcium score 
together to predict coronary artery disease was shown to be more robust than using FRE 
alone (AUC 0.907 versus AUC 0.801 respectively, both p value <0.001) 
Calcium scoring however cannot quantify vascular stenosis or assess non calcified 
and mixed plaque which may have features that render the plaque as vulnerable or at high 
risk for rupture due to presence of a lipid core or spotty calcifications. This underestimates 
the actual plaque burden. Contrast enhanced study of the coronaries gives us this additional 
information regarding plaque burden and degree of stenosis.  
 
Plaque burden: 
 
The study revealed moderate correlation between Framingham risk estimates 
(p<0.001) and each of the CT scores used to assess plaque burden (Pearson’s correlation 
co-efficient (r) = 0.401, 0.35, 0.34, 0.43 for SIS, SPS, SSS, MDPI respectively, all 
p<0.001).  
Contingency tables between NCEP risk categories and plaque burden scores 
showed that the association between the low, intermediate, moderately high and high risk 
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categories and the four CT scores assessing plaque burden score was significant (p value 
<0.001). It was observed that 10% patients in the low risk category, 30% in the 
intermediate risk category had coronary artery disease. Patients belonging to high risk 
group however showed higher plaque burden scores. 
Attention needs to be paid to the observation that 80% patients in the intermediate 
group, among those with coronary artery disease, had either moderate or heavy segment 
plaque scores. This is similar to findings in other studies that report conventional risk 
scoring systems underestimate coronary atherosclerotic plaque in intermediate risk 
population(39)(38). These results point out that even in the absence of known risk 
factors, that is in the low to intermediate risk groups, there is potential for development of 
cardiovascular events due to the presence of coronary artery plaque. This is the group of 
patients for whom, in the absence of an imaging evaluation, aggressive treatment 
strategies or lifestyle modifications would not be indicated.  
 
Plaque characterization: 
 
It was observed in this study that calcific plaque represented 77, 70, 83 and 81.50% 
in the low, intermediate, moderately high and high NCEP risk category patients 
respectively. This study showed that a higher proportion of patients in the intermediate risk 
group had non calcified plaque (23%). Non calcified plaque, along with large volume 
plaque are associated with a higher likelihood of complications like plaque rupture 
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resulting in an acute coronary event. These patients will therefore benefit from earlier 
interventions towards risk factor modification.  
Our results are similar to findings reported by Schneer et al in the Israeli 
population(40) and  Allajbeu et al in the Albanian population(39) that conventional risk 
scoring systems used in clinical practice predict fairly well the overall atherosclerotic 
plaque burden. In certain proportion of low and intermediate risk groups however, these 
risk scoring systems were inaccurate in predicting plaque burden. Our results differ from 
findings from Johnson et al (41) which state that traditional risk scoring systems are weak 
predictors of coronary artery plaque burden. Therefore, in most patients, conventional risk 
scoring systems can be used to guide therapy. This avoids unnecessary radiation exposure 
and risk related to intravenous iodinated contrast administration. However, CCTA can add 
significant and crucial details with regards to the coronary status in patients which will 
direct the treating clinician to the most appropriate treatment strategy. 
 Our results show that there is reasonable correlation between these risk groups and 
atherosclerotic disease burden that thereby suggests that low risk patients most often 
presents with lower plaque burden and severity and high risk patients present with higher 
plaque burden and severity. The intermediate risk group however shows association with 
both higher segment plaque scores and presence of vulnerable plaque. Therefore, patients 
in the intermediate NCEP risk categories would benefit from CCTA as it provides 
significant additional details regarding coronary artery plaque volume, degree of stenosis 
and plaque type, thus guiding further management.  
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CONCLUSION: 
 
In conclusion, it is evident that coronary CT angiography is an accurate, reliable 
noninvasive imaging tool, especially in patients in low and intermediate risk groups, for 
the diagnosis of early, subclinical CAD. It also has additional benefits of quantifying 
plaque burden and detecting the presence of vulnerable low density plaques.  
It has been demonstrated that there is moderate correlation between Framingham 
risk estimates and NCEP risk categories and presence of coronary artery plaque and the 
coronary artery disease burden in our study population, especially among the low risk and 
high risk groups.  
But among intermediate risk patients, the correlation of conventional risk scoring 
systems with plaque burden and vulnerable plaque was observed to be less robust. The 
results of our study suggests that coronary CT angiography should be considered in the 
intermediate risk group to guide planning of optimal therapy and preventive strategies.  
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LIMITATIONS 
 
The relatively small sample size is an obvious limitation of this study.  
 
The study was confined to a specific population of patients whose clinical condition did 
not warrant an invasive catheter angiography. So there is an obvious selection bias as 
patients with a higher suspicion for coronary artery disease are taken up directly for 
invasive catheter angiography over coronary CT angiography.  
 
Spectral imaging using use two X-ray tubes with different voltages to thus further 
characterize plaque composition was done as the study was started during the initial 
phases of computed tomographic imaging of the coronary arteries. This is an exciting 
new arena that we hope to venture into.  
 
This was a cross sectional study and the relationship between risk estimates and plaque 
burden and its progression along with long term cardiovascular outcome and prognosis 
requires further investigation.  
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ANNEXURES 
 
ANNEXURE 1a: Consent form and patient information sheet in English 
 
Format for Informed Consent Form for Subjects 
 
Study Title: Study title: A comparative study of conventional risk models and CT 
coronary angiography   
 
Study Number: ____________   
Subject’s Initials: __________________ Subject’s Name: 
_________________________________________   
Date of Birth / Age: ___________________________   
 
 (i)  I confirm that I have read and understood the information sheet dated ____________ 
for the above study and have had the opportunity to ask questions. [  ]   
(ii)  I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal rights 
being affected. [  ]   
(iii)  I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access. However, I understand that my identity will not be revealed in any information 
released to third parties or published. [  ]   
(iv)  I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s). [  ]   
(v)  I agree to take part in the above study. [  ]   
Signature (or Thumb impression) of the Subject/Legally Acceptable    
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Date: _____/_____/______      
Signatory’s Name: _________________________________         Signature:    
Or    
       
Representative: _________________   
Date: _____/_____/______   
Signatory’s Name: _________________________________    
Signature of the Investigator: ________________________   
Date: _____/_____/______   
Study Investigator’s Name: _________________________    
Signature or thumb impression of the Witness: ___________________________   
Date: _____/_____/_______   
Name & Address of the Witness: ______________________________   
For any querries, kindly contact Dr. Geethu Elizabeth Punnen, PG Registrar, department 
of Radiology, CMC, Vellore.Mobile – 9994982024 
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PATIENT INFORMATION SHEET 
 
Study title: A comparative study of conventional risk models and CT coronary 
angiography 
 
The following information is provided to inform you about this study and your participation 
in it. Please read the information carefully and you are free to ask questions regarding the 
study and the information given. Participation in this study is purely voluntary and you are 
free to withdraw from the study anytime. 
 
What is coronary CT angiography? 
Coronary computed tomography angiography (CCTA) is a heart imaging test that helps 
determine if plaque buildup has narrowed a person’s coronary arteries, the blood vessels 
that supply the heart. 
 
What is the purpose of this study? 
It is a non-invasive test which is useful for looking at the coronary arteries to assess if there 
is any block to the normal flow of blood to the heart. The results of this scan will help your 
doctor to know more about your disease condition and treat you better. The results of this 
study may reveal the usefulness of this test to identify coronary artery disease and will also 
help to treat other patients with similar illnesses better. 
 
What are the risks involved while being a part of this study? 
Your participation in this study is not associated with any added risks.  
 
  
Confidentiality 
Your participation in this study will remain confidential and shall be known only to the 
investigators. The results of the study will be published in medical journals, but your 
personal identity such as name and address will not be disclosed to anyone. 
 
Withdrawal from the study 
Participation in this study is purely voluntary and you can withdraw from the study anytime 
without explaining any reasons. It will not compromise your treatment in any way. 
 
 
Detailed information about the procedure 
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Before the test 
You have to give your consent in writing prior to the test. 
You will have to meet the doctor in CT Room 22 two days prior to your test, who will then 
record your heart rate and blood pressure. It is essential that during the test your heart rate 
is at a controlled rate to avoid blurring of pictures that are acquired by the machine. To 
keep your heart rate under control the doctor will give you medication, T Ivabradrine 5mg, 
for one and a half days. The doctor will also make sure it is safe for you to undergo the test 
after taking done your past medical history 
 
The day of the test 
The actual test takes only about 10 to 15 minutes. However, make arrangements to stay for 
2- 3hours from the time you arrive to the time you leave. 
Please arrive at CT Room 22 in the Radiology department one hour prior to the scheduled 
test time. 
You will be asked to change into a hospital gown and remove all jewellery. 
 
During the test 
The test takes only about 10 to 15 minutes. 
You will be asked to lie down on a table that goes into the CT scanner and connected to a 
machine that monitors your heart beat. 
Once the test starts, you will hear various sounds as the machine takes pictures. 
We will also prompt you with instructions. For example, we may ask you to hold your 
breath for 8 to 10 seconds at a time. 
It is important that you stay as still as possible because movements can create glitches in 
the pictures. 
 
After the test 
You may resume your normal activity immediately after the test. 
The test results will be sent to the doctor who is treating you in OPD by the following day. 
You will need to contact your treating doctor to discuss the results of your test. 
Keep any scheduled follow-up appointments with your primary doctor. 
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ANNEXURE 1b: Consent form and patient information sheet in Tamil 
 
 
 
 
 
 
ஆய்வில் பங்கேற்பதற்ோன தேவல் அறிந்த ஒப்புதல் வடிவம் 
ஒப்புதல் படிவம் 
ஆய்வின் பபயர்: காப ாநரீ சி. டி. அஞ்ச்சியயாகி ாப்பியில் இத
ய த்த நாளங்களளப் பற்றிய பரியசாதளை  
 
 
உங்களுக்கு யேலும் யகள்விகள் இருந்தால் பதாடர்பு யகாள்ள யவண்டிய 
பதாளையபசி எண்: Dr. கீத்து புன்ைன். 9994982024 
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ஆய்வின் பபயர்: இதயரத்த நாளங்களளப் பற்றிய பரிச ாதளை ( சி. டி. ஸ்சகன்) 
 
 
இந்த பரிச ாதளையின் முழுவிவரங்கள் இந்த ஒப்புதல் படிவத்தின் மூலம் ஆக உங்களுக்கு 
அறிவிக்க படுகிறது. இந்த பரிச ாதளைக்கு ஒப்புதல் தருவசதா அல்லது ஏற்க 
மறுப்பதற்சகா உங்களுக்கு முழு உரிளம உண்டு.  
 
காரராநரீ சி. டி. அஞ்ச்சிசயாகிராப்பி என்றால் என்ை? 
ரத்தநாளங்களின் அளமப்பு அல்லது அதன் குளறபாடுகளள கண்டறிய சமற்ரகாள்ளும் 
ச ாதளை.  
 
 
பரிச ாதளையின் பக்கவிளளவுகள் பற்றிய விவரம்: 
௧. கதிர்இயக்ககருவி உபசயாகித்தல் 
௨. இதயத்துடிப்ளப கட்டுப்படுத்தும் மருந்து ஐவபிராதின் உபசயாகித்தல் 
௩. கான்ட்ராஸ்ட் எைப்படும் ரத்த நாளங்களள துல்லியம்மாக படம் பிடிக்க உதவும் 
மருந்து உபசயாகித்தல் 
 
 
சமற்கூறியவற்ளற உபசயாகம் ர ய்யும் சில சநரங்களில்  ளத, நாளங்கள், நரம்புகள் 
பாதிப்பு அளடய சில வாய்ப்பு உள்ளது. 
 
 
ஆராய்ச்சியின் முடிவு என்ை? 
இது உங்கள் வியாதிளய கண்டறிய உதவக்கூடும்.இதைால் மற்றவர்களும் பயன் 
அளடவார்கள்.  
 
 
 
உங்கள் விவரங்கள் பாதுகாக்கபடுமா? 
இந்த ஆராய்ச்சி மருத்துவ இதழ்களில் ரவளிவரலாம். ஆைால் உங்கள் ரபயசரா, ர ாந்த 
விவரங்கசளா யாரிடவும் அறிவிக்கப்படாது. உங்களள பற்றிய தகவல்கள் அளைத்தும் 
ஆய்வாளர்களுக்கு மட்டும் ரதரிந்திருக்கும். சவறு யாரிடமும் ரதரிவிக்கப்படாது. 
 
ச ாதளையில் இருந்து விலகுதல்: 
நீங்கள் எந்த சநரத்திலும் இந்த ச ாதளையில் இருந்து விலகலாம், இது உங்கள் 
ரதாடர்ச்சியாை சிகிச்ள ளய எந்த வளகயிலும் பாதிக்காது. 
 
 
ச ாதளையின் விரிவாை விவரங்கள்: 
 
உங்களுக்கு யேலும் யகள்விகள் இருந்தால் பதாடர்பு யகாள்ள யவண்டிய 
பதாளையபசி எண்: Dr. கீத்து புன்ைன். 9994982024 
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ச ாதளையின் முன்: 
 
௧. சி.டி. அளற எண் 22இல் உள்ள மருத்துவளர  ந்தித்து இதயத்துடிப்பு, ரத்தஅழுத்தும் 
பரிச ாதளை ர ய்து  ரிபார்க்கசவண்டும். இங்கு இருந்து மருந்துகள் தரப்படும். ஏரைனில் 
ச ாதளை நாளன்று இதய துடிப்பு  ரியாை அளவு இருக்கசவண்டும். 
 
 
 
 
ச ாதளையின் நாள் அன்று: 
 
ச ாதளையின்சபாது ஒரு மணிசநரத்திற்கு முன்பு சி. டி. அளற 22இல் வரசவண்டும்.அங்கு 
வந்த பிறகு துணி மாற்றிக்ரகாள்ள சவண்டும். இந்த ச ாதளை10 -15 நிமிடங்கள்தான் 
இருக்கும். 
 
 
ச ாதளையின் சபாது: 
 
- அள யாமால் படுக்க சவண்டும் ர ால்லும்சபாது மூச்சி பிடித்து ளவக்கசவண்டும் 
 
 
 
 
 
 
ச ாதளையின் பின்: 
 
உடசை  ாதாரண நிளலக்கு வந்துவிடலாம் 
இந்த ச ாதளையின் ரிசபார்ட் உங்கள் மருத்துவரிடம் அனுப்பப்படும். நீங்கள் உங்கள் 
மருத்துவளர பார்த்து உங்கள் ரிசபார்ட்ளட பற்றி ரதரிந்துரகாள்ளலாம். 
 
 
 
 
 
 ANNEXURE 3: Consent form and patient information sheet in Telugu 
 
உங்களுக்கு யேலும் யகள்விகள் இருந்தால் பதாடர்பு யகாள்ள யவண்டிய 
பதாளையபசி எண்: Dr. கீத்து புன்ைன். 9994982024 
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ANNEXURE 1c: Consent form and patient information sheet in Telugu 
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ANNEXURE 1: Consent form and patient information sheet in Hindi 
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ANNEXURE 1d: Consent form and patient information sheet in Hindi 
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रोगी जानकारी पत्र 
अध्ययन का नाम: कोरोनरी धमनी की बीमारी की जााँच म ेहृदय के सी. टी स्कान की भमूमका 
मनम्न जानकारी इस अध्ययन और उस में अपनी भागीदारी के बारे में समूचत करने के मिए प्रदान की जाती ह।ै ध्यान से जानकारी पढ़ सकते 
हैं और आप को दी गई जानकारी के बारे में सवाि पछू सकते ह।ै। इस अध्ययन में भागीदारी परूी तरह स्वैमछछक ह ैऔर आप अध्ययन से 
कभी भी वापस िेने के मिए स्वतंत्र हैं। 
कोरोनरी सी.टी. एजंजयोग्राफी क्या है? 
कोरोनरी सीटी एमंजयोग्राफी हृदय की खनू की नामियों की जााँच की एक सिुभ मवमध ह ैमजसके द्वारा रक्त की प्रवाह की बाधा को आसानी से 
दखेा जेया सकता ह ैऔर मचमक्तसा मेई सधुार मकया जा सकता ह।ै इस अध्यन से प्राप्त जानकारी का उपयोग अन्य रोमगयों की मचमकत्सा मे 
मद्द कर सकमत ह।ै  
क्या कोरोनरी सी टी आंजजयोग्रफी से जकसी प्रकार की खतरा है? 
अन्य प्रक्कआर की स्रीट टी के मकुाबिाए म ेइस जााँच से आपको कोई अमतररक्त खरा नहीं ह।ै  
क्या आपका व्यागततगत जििरण गोपनीया रखा जायेगा? 
इस अध्यन से ममिे पररणाम को मकसी भी जननि म ेप्रकामित मकया जायेगा, पर आपका नाम मकसी भी जगह पर नहीं मिया जायेगा। परंत ु
आपके मचमकत्सािय के ररकॉर्न की समीक्षा हो सकते ह ैउन िोगो के द्वारा जो इस अध्यन से जडेु ह,ै और ये आपकी जानकारी के बेगार हो 
सकता ह।ै 
क्या आप इस अध्यन से अपना नाम िापस ले सकते है? 
इस अध्यन स्वेचक ह,ै आप इस अध्यन से अपना नाम कभी भी वापस िे सकते ह।ै इस से आपका कोई भी नकुसान नहीं होगा। 
 
 
जााँच की बारे मे जानकारी 
टेस्ट के पेहले: 
किसी भी प्रिार िी अधिि जानिारी िे लिये िृपया सपंिक  िरे डाक्टर गीत ूपणु्णन (९९९४९८२०२४) या  
email: gpunnen@gmail.com 
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आपको सहमती पत्र पर हस्ताक्षर करने होगे। 
रूम २२ की र्ॉक्टर को टेस्ट की दो मदन पेहिेे ममिना होगा। वहााँ आपका पल्स और बी.पी. िे जायेगा। स्कान के दो मदन पेहिेे से हृदय का 
गमत धीमी करने के मिये एवाब्रेमर्न दवा खाना पडता ह।ै 
 
 
टेस्ट के जिन: 
इस टेस्ट को परूा होने के मियए १० से १५ मीनेटोका वक्त िगता ह।ै 
कृपया टेस्ट के समय से एक घंटा पेहिेे आप सी टी रूम २२ म ेपह चंे 
आप को आसपाताि के कपडे पेहनने होंगे 
 
 
टेस्ट के िौरान: 
आपको सी टी स्कान तबिे पर िेटना होगा। इसके बाद आपके हृदय धर्कनोका रेकॉमर्िंग मकया जायेगा। सी.टी. स्कान चाि ूहोनेप ेआपको 
अिग अिग तरह की आवाज सनुाई देंगे। 
 
आपको अिग अिग सचूनाये मदया जायेगी, जैसे की आप को ८ से १० सेकंर् के मिये सांस बंद करेने को कहा जायेगा 
इस टेस्ट के दौरान आपको मबल्कुि महिना नहीं ह।ै 
 
 
टेस्ट के बाि: 
इस टेस्ट के बाद तरंुत आपका रोजका काम चािू कर सकत ेह।ै  
टेस्ट के ररपोटन आपके र्ॉक्टर के पास भजेे जायेंगे। 
आप आपके दोटॉर से ममिके इस टेस्ट के ररज़ल्ट के बारे म ेजानकारी प्राप्त कर सकत ेह।ै 
 
 
 
 
 
 
 
 
 
किसी भी प्रिार िी अधिि जानिारी िे लिये िृपया सपंिक  िरे डाक्टर गीत ूपणु्णन (९९९४९८२०२४) या  
email: gpunnen@gmail.com 
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ANNEXURE 2: Data collection form 
 
1. Name                                                      Hospital no    
2. Referring unit: 
3. Reason for referral: 
1. Atypical chest pain 
2. Inconclusive treadmill 
3. Family history 
4. Several risk factors – smoking/ alcohol/obesity 
5. Pre-operative clearance screening 
6. Patient anxiety 
7. Others (please specify) __________________ 
 
4.  Age:              Date of birth  
 
5. Sex 1. Male 2. Female 
6. Do you smoke? 1. Yes 2. No 
7 a. Do you have hypertension? 1. Yes 2. No 
7 b. If yes: are you on medications for hypertension: 1. Yes 2. No 
8. Do you have diabetes? 1. Yes 2. No 
9. a. Have you checked your cholesterol levels? 1. Yes 2. No 
9. b. If yes , are your cholesterol levels high 1. Yes 2. No 
9. c.  Are you on treatment for high cholesterol levels 1. Yes 2. No 
10. 
a. 
Does anyone in your immediate family have heart 
disease   
1. Yes 2. No 
 
B. If yes, who had heart disease and at which age  
 
1. Father (specify age)                                               2. Mother (specify age) 
 
        3.   Brother (specify age)                        4.  Sister (specify age) 
 
C. Is the history significant?   1. Yes                2. No 
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11. Weight (kg):                               12. Height(cm):    
   
13. Blood Pressure (mm Hg): 
 
 
14. BMI 
 
15. Total cholesterol (mg/dl) 
  
16. LDL (mg/dl) 
 
 
17. Triglycerides (mg/dl)  
 
 
18. HDL (mg/dl)  
 
 
19. Framingham risk score: 
 
20. NCEP core risk category: 
 
21. Coronary artery disease   - any plaque:  
1. Present  2. Absent  
22. Calcium score: 
1. <10AU (nonsignificant) 
2.10-100AU (mild 
3.101-400(moderate) 
4. >400 (severe) 
No of vessels involved:  
23. Vessels involved: 
1. RCA 2. Left Main  3. LAD  4. LCX  5. Marginal 6. Diagonal 7. Other 
 
 
 
 
 
 
 
 
Systolic Diastolic  
  
   
   
   
   
1. Underweight <18.5 
2. Normal weight =<18.5 – 24.9 
3. Overweight 25 – 29.9 
4. Obesity >=30 
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24. Segment plaque score (0- 48) 
0 – trace 
1- Mild 
2- Moderate 
3- Heavy 
 
 
 
 
 
 
 
 
 
 
 
25. Segment involvement score (0-16) 
0- Absent, 1- Present 
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26. Segment stenosis score: 
<30%- very mild - 0 
30- 49%-  mild - 1 
50-69% - moderate - 2 
>=70% severe - 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Total score 
Segment involvement score   
Segment plaque score  
Segment stenosis score  
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27.Modified duke’s prognostic criteria 
Modified Duke’s 
prognostic 
criteria 
 Tick as appropriate 
Duke 0 No stenosis  
Duke 1 Very mild/ Mild stenosis   
Duke 2  Two or more mild stenoses with one proximal or one 
moderate stenosis 
 
Duke 3  Two moderate stenoses or one severe stenosis  
Duke 4 Three moderate stenoses, two severe stenoses, or one severe 
stenosis of the proximal left anterior descending (LAD) 
coronary artery 
 
Duke 5 Three severe stenoses or two severe stenoses with the 
proximal LAD involved 
 
Duke 6  Moderate or severe left main artery stenosis.  
 
 
28.Coronary plaque characteristics: 
Plaque Non calcified (1) Mixed (2)  Calcified (3) 
PI    
P2    
P3    
P4    
P5    
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ANNEXURE 3: IRB Protocol 
 
APPLICATION FOR IRB APPROVAL OF OBSERVATIONAL 
(CASE-CONTROL / COHORT/ CROSS-SECTIONAL) STUDIES 
 
CHRISTIAN MEDICAL COLLEGE, VELLORE 
(Please complete Sections I to III and submit with all supporting documents) 
 
SECTION I 
 
Fluid Research Funding 
 
 
Title of Research:  A comparative study of conventional risk models and CT coronary 
angiography 
 
Title of Study (for lay public): To compare the scores of CT based coronary artery tests and 
conventional clinical risk factors for coronary artery events such as heart attack and death due 
to heart attack 
Acronym if any: nil 
Unique Protocol ID, if any: nil 
Name of the Principal Investigator: Dr. Geethu Elizabeth Punnen 
Designation / Department / Unit / of Principal Investigator: 
PG Registrar 
Department of Radiodiagnosis and Imaging 
Christian Medical College 
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Employment Number:29376 
 
Address for communication (including telephone and fax numbers and email id):  
Dr. Geethu Elizabeth Punnen  
PG registrar 
Department of Radiodiagnosis and Imaging 
Christian Medical College 
Vellore -632004 
Tamil nadu 
Phone no: 9994982024 
E-mail: gpunnen@gmail.com 
If Post Graduate Registrar / Fellowship: 
Enrollment date of PG Course:  05/2014 
Completion date of PG Course: 04/2017 
6.    Name of Guide (for Post-Graduate Registrar / Fellowship): Dr. Elizabeth Joseph 
Employment Number: 20071 
Address for communication 
 Dr. Elizabeth Joseph 
Professor 
Department of Radiology  
Christian Medical College & Hospital  
Vellore Tamil Nadu 
Mobile: 09488934984 
Radiology Office: 0416-228-3012/2027 
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Email: josephg@cmcvellore.ac.in 
 
Name and Designation of Co-Investigator(s), Employment Number and Address : 
Dr. Aparna Irodi 
Associate professor 
Department of Radiology 
Christian Medical College & Hospital 
Vellore Tamil Nadu 
Radiology office: 0416-228-3012/2027  
Employment no: 28382 
 
Dr. Binita Riya Chacko 
Associate professor 
Department of Radiology 
Christian Medical College & Hospital  
Vellore Tamil Nadu 
Radiology office: 0416-228-3012/2027  
Employment no: 31893 
 
Dr. Leena R. V. 
Assistant professor 
Department of Radiology 
Christian Medical College & Hospital  
Vellore Tamil Nadu 
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Radiology office: 0416-228-3012/2027  
Employment no: 28374 
 
 
Dr. Paul V George 
Professor of Cardiology 
Department of Cardiology  
Christian Medical College & Hospital 
Vellore  Tamil Nadu 
Employment no: 
 
Department of Institution where the research will be carried out:  Department of Radiology, 
Christian Medical College, Vellore 
Names and addresses of other institutions where research will be carried out: nil 
Duration of the Scheme: 15 months 
Source/s of Monetary or Material Support 
Internal - Fluid /Major Research Grant : FLUID RESEARCH GRANT 
External     : nil 
Departmental fund     : nil 
Objectives and aims of study 
 
AIM:  
To study the degree of correlation between conventional risk models as assessed by the 
National Cholesterol Education Program (NCEP) - Adult Treatment Panel (ATP) III guidelines and 
coronary atherosclerotic disease burden as well as risk prediction as estimated on Coronary CT 
Angiography (CTCA) in a tertiary care hospital in South India  
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Primary objectives: 
 
5. To determine the NCEP Core risk category among patients referred for a coronary CT 
angiography  
 
6. To assess the calcium score (CACS), segment plaque score (SPS), segment involvement 
score (SIS), segment stenosis score (SSS) and Modified dukes prognostic score, based on 
coronary  CT angiography in the same group of patients  
 
7. To describe plaque characteristics as lipid rich, fibrous, fibrocalcific and calcified plaques 
 
8. To correlate the risk prediction of Modified Duke’s score with the NCEP core risk score. 
  
 
Secondary objectives( long term): 
 
1. To describe the change in medical management, in the referred patients, post coronary 
CT angiography. 
 
  
Summary of the proposed research scheme (250 words). 
 
STUDY PERIOD: Study will be conducted in the Department of Radiology and Cardiology 
between January 2015 to April 2016 
 
Using a retrospective review, a sample of 144 (72 cases and 72 controls)was arrived at to detect 
20% difference in high risk (i.e above 20% of Framingham risk score) among those with 
coronary artery disease and those without coronary artery disease, with a power of 80% and 
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5% type 1 error using two tailed chi square test, assuming that 30%  of patients are high risk 
group among those with coronary artery disease on CT angiogram and 10% of patients are of 
high risk group in those with no coronary artery disease on CT angiogram 
 
All consecutive adult patients advised to undergo coronary CT angiography for suspected 
coronary artery disease will be recruited for the study, assuming they have no contraindication 
for the same. 
Informed consent will be obtained by the principal investigator. 
The cost of the study will be arranged by the patient themselves when affordable. If they are 
unable to afford the scan, provision for the scan can be arranged for them through the grant for 
the research project. 
Demographic details of the patient with relevant history of risk factors, along with lipid profile 
values will be collected and the Framingham risk score will be calculated. Risk stratification of 
each patient according the NCEP core risk score will be performed.  
The coronary CT angiography will be performed in CT Room 22 in the Radiology department in 
the GE HD 750 machine using standardized protocol for coronary artery imaging. The scan will 
be analyzed on 3D workstation and reported by the principal investigator in a standardized 
format and checked by a radiologist of professor grade (Guide). 
Calcium score, the total plaque burden as assessed by the segment plaque score, segment 
involvement score, segment stenosis score and Modified duke’s prognostic index, and the 
plaque characteristics will be assessed on each scan. Examinations which are of poor image 
quality will be excluded from the study. 
 Analysis will include the assessment of the above mentioned scores among the patient group 
as well as the degree of correlation between the NCEP core risk score and the Modified Duke’s 
prognostic index in predicting a coronary event  
 
  
Present Knowledge and relevant bibliography  
Cardiovascular disease is the leading cause of mortality in the world. (1)Also, Indians have been 
shown to have a higher risk factor burden at younger ages compared with Western 
populations; thereby risk prediction models developed in Western countries may 
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underestimate CHD risk. A high short-term risk (≥10% 10-year risk or diabetes) for CHD was 
prevalent in more than one-fifth of the population.(2) There is a substantial lack in evidence 
regarding risk based coronary artery disease prediction models in the Indian population.  
 
Risk factors for atherosclerosis and cardiovascular disease (CVD), including age, sex, lipid levels, 
smoking and blood pressure, are incorporated in risk algorithms that are used to predict an 
individual’s absolute risk for CVD in the general population. Widely used risk assessment tools 
like the Framingham risk score (FRS) or the National Cholesterol Education Program guidelines  
guide initial management of patients at risk for coronary artery disease. Although these risk 
factors are useful to predict risk in populations, their accuracy in predicting cardiovascular risk 
in individuals varies considerably across populations(3). This can potentially lead to patients in 
high risk CHD group with limited or no plaque to be treated to life-long drug therapy, and those 
with low risk CHD but with significant plaque might be undertreated or not treated at all. Also 
the FRS does not incorporate family history and many of the components of metabolic 
syndrome, both of which are important risk factors for coronary heart disease(3). It is also 
known to underestimate subclinical atherosclerotic risk in women(4). 
Imaging is considered superior to risk estimation of risk charts since:  
 Direct detection of atherosclerosis is better than identifying only risk factor exposure  
 Re-classiﬁcation of low-risk subjects into higher strata may guide therapy 
 The identiﬁcation of high-risk subjects might improve adherence to risk-modifying 
therapy(4). 
Coronary CT angiography (CCTA) has emerged as an accurate non invasive method for the 
evaluation of coronary artery disease (CAD), stenosis severity, extent, and distribution. It 
provides direct visualization of plaques, enabling its characterization, an advantage over 
conventional coronary angiography.  
 
Calcium score (CACS): 
The quantitative CACS protocol was introduced by Arthur Agatston and his colleagues in 1990 
and has still remained the standard method in CACS. Any structure which has densities of 130 
Hounsfield units (HU) or more and having an area of 1 mm2 or more will be segmented as 
calcified focus and those foci overlying the anatomic site of coronary arteries will be considered 
to represent calcified plaques. . The stratified density scores 1, 2, 3 and 4 represent the highest 
densities 130-199 HU, 200-299 HU, 300-399 HU and ≥ 400 HU, respectively. 
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The total Agatston score (AS) of each individual is calculated by summing the scores of every 
calcified focus through all of the coronary arteries (5) 
It is established that coronary artery calcium scoring is a strong tool for prediction of coronary 
events.(6). 
The CCTA is of more important role than CACS for CAD assessment; therefore, following CACS, 
patients may undergo CCTA to assess CAD likelihood. Hence, CACS has been considered to be a 
“gatekeeper” for CCTA(7) 
 
 There is increasing data to suggest that contrast enhanced computed tomography of the 
coronary arteries which help detect both calcified and non calcified plaques, thus giving a more 
accurate estimate of the burden of atherosclerosis 
 
Segment plaque score(SPS): 
The segment plaque score is an indicator of plaque burden. For each segment, the amount 
(volume) of plaque, whether calcified or not will be scored as none or trace (0), mild (1), 
moderate (2), or heavy (3).In case of multiple lesions in a given segment, the amount is 
classified by considering the segment as a whole. The SPS for each patient is calculated as the 
sum of individual segments’ burdens. 
 
Segment stenosis score (SSS): 
Segment stenosis score is similar to segment plaque score but it uses an estimate of the 
diameter of the stenosis per segment rather than volume of plaque. It is scored as very mild < 
30%, moderate 50-69%, or severe >=70%. Sum of all the individual segments is called the 
segment stenosis score. 
 
Segment involvement score (SIS): 
Each segment is scored according to the its involvement as absent or trace or as present, 
(1)absent, (2) present 
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Modified Duke’s prognostic index: 
Modified Duke’s prognostic index has been derived from conventional angiographic data and is 
shown to correlate with cardiac mortality. Higher the Duke’s score, higher is the risk. 
The stenosis is visually graded with the varying combination of plaque in different vessels. The 
area a total of six Modified Duke’s criteria(8) 
 
Plaque characteristics: 
Plaques can be divided as calcified, mixed or non calcified plaques. But with advance in analysis 
workstations, based on Hounsefeild units plaques are now classified as lipd(fatty -100 to 29HU), 
fibrous (30-189), fibro-calcific (190-349), calcified(>350) plaque. 
Calcified plaque(CAP) represents only approximately 20% of the total atherosclerotic plaque 
burden  and is thought to be present in the advanced stages of atherosclerosis within an 
individual plaque whereas non calcified plaques(NCAP) is considered to be a feature of early 
atherosclerosis. Furthermore, there is growing evidence suggesting that NCAP might be 
associated with acute coronary syndrome. However, whether the relation of CAP to NCAP is 
dependent of age, and whether the presence and extent of NCAP, mixed coronary 
atherosclerotic plaque (MCAP), and CAP are similarly associated with cardiovascular risk factors 
remains unclear.(9) 
There is recent evidence which suggests that  Coronary risk stratification using a risk factor 
only–based scheme is a weak discriminator of the overall atherosclerotic plaque burden in 
individual patients (8) The Framingham and NCEP core risk categories do not reflect the amount 
of coronary atherosclerotic disease detected at coronary CTA in individual patients. The study 
by Johnson et all (8) confirms the observations of others who used calcium scoring and extends 
the conclusion to include all plaque, calcified and uncalcified, detected at coronary CTA. 
Coronary CTA may provide incremental information beyond risk factors and may significantly 
influence therapeutic decisions regarding prophylactic therapy for CAD (8). 
 
The purpose of this study will be to evaluate the degree of correlation between the 
conventionally used risk models such as the Framingham risk score, along with the NCEP Core 
risk score and the Modified Duke’s score in predicting a coronary event as well as the severity 
of coronary artery disease as assessed by various scores on coronary CT angiography 
 
 123 
 
1.  WHO | The top 10 causes of death [Internet]. WHO. [cited 2014 Nov 18]. Available from: 
http://www.who.int/mediacentre/factsheets/fs310/en/ 
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Structured abstract: 
AIM:  
To study  the degree of correlation between conventional risk models and coronary 
atherosclerotic disease burden s well as risk prediction  as estimated on coronary CT 
angiography in a tertiary care hospital in South India  
 
Primary objectives: 
1. To determine the NCEP Core risk category among patients referred for a coronary CT 
angiography  
 
2. To assess the calcium score (CACS), segment plaque score (SPS), segment involvement 
score (SIS), segment stenosis score (SSS) and Modified dukes prognostic score, based on 
coronary  CT angiography in the same group of patients  
 
3. To describe plaque characteristics as lipid rich, fibrous, fibrocalcific and calcified plaques 
 
4. To correlate the risk prediction of Modified Duke’s score with the NCEP core risk score. 
  
Secondary objectives( long term): 
To describe the change in medical management, in the referred patients, post coronary CT 
angiography. 
 
 
Design of data collection: Prospective descriptive study   
  
Cases: Patients with suspected/diagnosed coronary artery disease, which are advised to 
undergo coronary CT angiography in the period between Jan 2015 and April 2016.      
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Sample size : 144 cases 
 
Methodology: 
All consecutive adult patients advised to undergo coronary CT angiography for suspected 
coronary artery disease will be recruited for the study, assuming they have no contraindication 
for the same. Informed consent will be obtained by the principal investigator. 
 
Demographic details of the patient with relevant history of risk factors, along with lipid profile 
values will be collected and the Framingham risk score will be calculated. Risk stratification of 
each patient according the NCEP core risk score will be performed. These parameters will be 
compared with findings on CT coronary angiography.  
 
The scores that will be assessed are : 
1. Calcium score 
2. Segment plaque score 
3. Segment involvement score 
4. Segment stenosis score 
5. Modified Duke’s prognostic criteria 
6. Coronary plaque characteristics 
 
Outcome measures: 
 Burden of coronary artery disease among the NCEP core risk groups as assessed by 
calcium score, segment plaque score, segment stenosis score, and segment involvement 
score 
 The distribution of plaque characteristics among the risk groups 
 The correlation of risk prediction of conventional risk models (NCEP ATP III guidelines) 
and Modified Duke’s prognostic index in predicting a coronary event 
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Detailed diagrammatic Algorithm of the study  
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Detailed research plan: 
Study population recruitment.  
 
The study will be conducted in the Department of Radiology, Christian Medical College and 
Hospital, Vellore from the period between Jan 2015 and April 2016.  
 
Sampling strategy 
 
Patients with suspected/diagnosed coronary artery disease, who present to Cardiology services 
and fulfill the inclusion criteria, have none of the exclusion criteria, and have given consent to 
be a part of the study will be included 
 
Sample size calculation: Using a retrospective review, a sample of 144 (72 cases and 72 
controls)was arrived at to detect 20% difference in high risk (i.e. above 20% of Framingham risk 
score) among those with coronary artery disease and those without coronary artery disease, 
with a power of 80% and 5% type 1 error using two tailed chi square test, assuming that 30%  of 
patients are high risk group among those with coronary artery disease on CT angiogram and 
10% of patients are of high risk group in those with no coronary artery disease on CT angiogram 
 
Inclusion criteria 
Patients with suspected coronary artery disease with the following complaints and are advised 
to undergo coronary CT angiography in the period between Jan 2015 and April 2016: 
8. Atypical chest pain, dyspnea or syncope 
9. Inconclusive treadmill 
10. Not fit for invasive catheter coronary angiography  
11. Family history 
12. Several risk factors – smoking/ alcohol/obesity 
13. Pre operative clearance screening 
14. Patient anxiety 
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 Exclusion criteria  
Patients with contraindication to the administration of iodinated contrast 
Previous history of myocardial infarction, stenting, coronary artery bypass graft stenting 
Poor image quality  
Pregnancy 
 
Design of data collection:  Prospective descriptive study 
 
CT coronary angiography 
This test uses intravenous contrast agents to enable visualization of the coronary arteries and 
to look for any abnormalities of the coronary arteries such as suspected abnormal anatomy, 
presence of coronary artery plaques, narrowing of coronary arteries. Calcium score is a 
standardized score which quantifies the amount of calcified plaque in the coronary artery.  
The cross-sectional images generated during a CT scan are then reformatted and reconstructed 
in multiple planes and reviews. Three dimensional images will be generated as well. These 
images can be viewed on a computer monitor. 
 
Benefits and risks of the procedure: 
Benefits 
CCTA is not invasive. An alternative test, cardiac catheterization with a coronary angiogram, is 
invasive, has more complications related to the placement of a long catheter into the arteries 
and the movement of the catheter in the blood vessels, and requires more time for the patient 
to recover. 
A major advantage of CT is that it is able to view bone, soft tissue and blood vessels all at the 
same time. It is therefore suited to identify other reasons for your discomfort. 
CT examinations are fast and simple, can be performed even if you have a medical device of any 
kind, unlike MRI 
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Risks 
There are no added risks to patients enrolling in the study. The risk involved is common to all 
undergoing a CT scan. 
The risks of the procedure are very small and are associated with the use of the drug ivabradine 
and intravenous contrast agent. When receiving Ivabradine, the patient may have bradycardia 
which can be symptomatic.  It often presents with lightheadedness, dizziness, fainting.  
If a large amount of x-ray contrast material leaks out from the vessel being injected and spreads 
under the skin where the IV is placed, skin damage or damage to blood vessels and nerves, 
though unlikely, can result.  
There is always a slight chance of cancer from excessive exposure to radiation. However, the 
benefit of an accurate diagnosis far outweighs the risk. 
The effective radiation dose for this procedure varies. The reported effective radiation doses for 
retrospectively gated, single-source, 64-slice CT scanning have ranged from 9.5-21.4 mSv. 
However, various technologies and techniques have made it possible to lower the dose to less 
than 5 mSv are possible in some patients.  
The ALARA (as low as reasonably achievable) principle applies to all studies. This principle calls 
for patient-specific adjustment of scanner settings to the patient's body habitus so that the 
lowest possible tube current setting that still results in a diagnostic study can be chosen. 
The risk of serious allergic reaction to contrast materials that contain iodine is extremely rare, 
and radiology departments are well-equipped to deal with them. Severe complications such as 
the possibility of heart attack and/or death are extremely rare. The careful monitoring of your 
blood pressure and continuous heart monitoring serve to minimize the small risks of the test. 
 
Before the test 
The patient on being advised by the cardiologist for CT coronary angiography will be sent from 
the OP booking counter to CT Room22 for receiving an appointment date for the test. The 
radiographer in CT Room 22 will then inform the primary investigator who will then meet the 
patient for the test. It is essential that the patient has to be seen at least 2 days before the test 
in the radiology department.  The patient will then be asked questions about his/her medical 
history and the medication(s) he/she is taking, any history of previous contrast reaction, any 
history of asthma, allergies. Creatinine values will be checked and recorded. This is to make 
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sure it is safe to have a contrast enhanced CT coronary angiogram. The procedure will also be 
explained to the patient in detail and the ‘patient information sheet’ will be given.  
Their pulse and blood pressure will be measured. If heart rate is more than 65 beats/ minute, 
they will be given T. Ivabradine 5mg, which is a selective heart rate lowering drug. A total of 4 
tablets to be taken for one and a half days, in the night 2 days prior to the scan and in the 
morning and in the night on the previous day of the scan. The last dose will be taken in the 
morning on the day of the scan. 
 
The patient will be asked to strictly adhere to the following: 
 Have a light meal and water / juice / coffee / tea prior to the appointment. 
 Regular medications as instructed by the treating doctor. 
 All male patients must shave their chest. 
 Avoid wearing jewellery 
 
Day of the test 
Including all preparations, the CT coronary angiography scan usually takes about 15 minutes if 
the heart rate is slow and steady. The patient is to arrive at CT Room 22, one hour prior to the 
scheduled test time. Patient will be asked to change into a hospital gown and remove all 
jewellery. One intravenous cannula (usually 20G) will be placed. 
 
Demographic details will be collected. Heart rate, systolic and diastolic blood pressures will be 
measured in the sitting position at baseline. Height, weight and waist circumference at the level 
of the umbilicus will be measured. If and when the heart rate is in the acceptable range for CT 
coronary angiogram, the test will be done. 
 
 An individual whose arterial blood pressure is 140/90 mm Hg or more or is taking 
antihypertensive medications will be classified as having hypertension. An individual with a 
non-fasting plasma glucose concentration of at least 200 mg/dl, or fasting plasma glucose level 
of at least 126 mg/dl, or is being treated with anti-diabetic medication will be considered to 
have diabetes. An individual with a body mass index (BMI) (calculated as weight divided by 
height squared) of 30 kg/m2 or more will be considered to be obese. A smoker is defined as an 
individual who smoked at least one cigarette per day or had quit smoking during the previous 
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year. Hypercholesterolemia is defined as a total serum cholesterol level of 240 mg/dl or more 
or a serum triglyceride level of 200 mg/dl or more (or both) or use of a lipid-lowering agent. 
Individuals were considered as having a positive family history, when they had first-degree or 
second-degree relatives with premature cardiovascular disease.  
 
During the test 
Just before the test, when the patient is on the scanning table, an anxiolytic, Inj Midazolam 
0.25mg, diluted in 1 ml of saline will be given intravenously along with 1 puff of nitroglycerine 
spray, a vasodilator. 
The technologist will clean three small areas of the patient’s chest and place electrodes (small, 
sticky discs) on these areas. The electrodes are attached to an electrocardiograph (ECG) 
monitor, which shows the heart's electrical activity during the test. 
A non-contrast scan will be done for calcium scoring. Intravenous contrast will be administered 
using a pressure injector along with a saline chase to remove contrast from the right side of the 
heart. The scanning table will move in and out of the machine depending on the type of scan 
done. 
After the scan, the technologist will ensure that the images taken are of high enough quality for 
accurate interpretation. The intravenous cannula will be then removed 
 
Machine: GE Advantage 750 HD 64 slice dual energy CT machine 
 
Imaging protocol: Retrospective or prospective ECG gated CT coronary angiogram will be 
planned according to the patient’s heart rate. 
 
As with all CT applications, the ALARA (as low as reasonably achievable) principle applies. This 
principle calls for patient-specific adjustment of scanner settings to the patient's body habitus 
so that the lowest possible tube current setting that still results in a diagnostic study can be 
chosen. 
 
Image reconstruction  
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The  phase with minimal cardiac motion is preferably chosen for placement of the image 
reconstruction window. The transverse source images will be initially reviewed to obtain 
general information about the presence, location, and composition (calcified vs noncalcified) of 
atherosclerotic lesions. Once lesions are detected, stenosis severity is evaluated by using simple 
visualization tools that enable a more comprehensive and condensed display of the data set.  
Maximum intensity projection and multiplanar reconstruction tools are used, along with 
dedicated analysis software for grading of lesions 
 
 Personnel. The coronary CT angiography studies will be reported provisionally by the principal 
investigator, which will then be approved by a radiologist of professor grade  
 
 Statistical methods. 
Categorical variables will be represented using percentages 
Continuous variables will be represented using mean and standard deviation, median and inter-
quartile range. “Pearson’s correlation coefficient and t test” will be used to determine the 
correlation between the variables , framingham risk score and the CT scores. 
 
 Interpretation. Clinical data will not be taken into consideration while reporting the imaging 
findings. 
 
Unclear results. Utmost effort will be taken to avoid any artifact or error in the CT scan and its 
report 
 
Missing data. Utmost effort will be made to get back any missing information with regards to 
diagnosis and imaging report 
 
Complete budget plan for all studies  
Coronary CT angiography is a fairly new imaging avenue in our institution. It is not yet fully 
incorporated into the routine protocol for diagnosis of patients with intermediate risk of 
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coronary artery disease due to financial constraints.  We would like to request for FLUID 
research grant to fund for the cost of the Coronary CT Angiography test for the period of this 
research project so that patients who cannot afford this study can be included as 
recommended by the referring clinician. We hope that the referring doctors will help in making 
an accurate judgment regarding patients who deserve concession. 
 
The proposed budget is as follows:  
S.no Item Cost per patient No of patient Total  
1 Coronary CT angiogram 11,000 9 99,000 
   Total 99,000 
 
 
Name & designation of the statistician involved in your project for Statistical 
Analyses: Dr. Antonisamy B 
 
 
Informed Consent Documents (patient information sheet, investigator’s brochure, drug 
information etc and informed consent document) : enclosed 
 
Publication Plans: (List all potential authors and their likely contributions) 
(Please tick √ appropriate box) 
 
Inter-departmental cooperation: (Please describe the arrangements with institutional 
diagnostic service units/departments that are being used for this research project, if 
applicable). 
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            Section II 
 
APPLICATION FOR APPROVAL FROM ETHICS COMMITTEE OF THE INSTITUTIONAL REVIEW 
BOARD OF CMC VELLORE FOR ALL OBSERVATIONAL (CASE CONTROL, COHORT & 
OBSERVATIONAL) STUDIES IN HUMAN SUBJECTS 
 
1. Please provide a brief summary of the justification, objectives and methods in lay 
language, avoiding technical terms.  
Coronary artery disease, also known as ischemic heart disease means that one or few of the 
many arteries supplying the muscles of the heart are diseased and fully or partially plugged. 
A substance called plaque builds up in the arteries that supply blood to the heart causing it 
to get plugged. Plaque is made up of cholesterol deposits, which can accumulate in your 
arteries. Atherosclerosis is a condition that occurs when too much plaque builds up in your 
arteries, causing them to narrow.  
 
Heart disease is the leading cause of death in the world and people of all ages and 
backgrounds can get the condition. Various conditions can increase the risk of developing 
heart disease, such as high blood pressure, smoking, LDL cholesterol. Not all cholesterol is 
bad for the heart. Some cholesterol is often termed "good," and some often termed "bad." A 
higher level of high–density lipoprotein cholesterol, or HDL, is considered "good," and gives 
some protection against heart disease. Higher levels of low–density lipoprotein, or LDL, are 
considered "bad" and can lead to heart disease. Several other medical conditions and lifestyle 
choices can also put people at a higher risk for heart disease, including: 
 Diabetes 
 Overweight and obesity 
 Poor diet 
 Physical inactivity 
 
To determine the risk of a heart attack there are scoring systems which employ clinical and lab tests. 
However the predictability of these tests are uncertain, which means that there is a potential chance 
that patients in high risk CHD group with limited or no plaque to be treated to life-long drug therapy, 
and those with low risk CHD but with significant plaque might be undertreated or not treated at all. 
The gold standard to asses heart vesses is coronary angiogram,which is invasive, has more 
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complications related to the placement of a long catheter into the arteries and the movement of the 
catheter in the blood vessels, and requires more time for the patient to recover.  
 
Computed tomography, more commonly known as a CT scan, is a diagnostic medical test that, like 
traditional x-rays, produces multiple images or pictures, in much greater detail, of the inside of the 
body Coronary CT scan is a test when the patient receives iodine-containing contrast material (dye) 
as an intravenous (IV) injection to ensure the best possible images of the heart blood vessels. 
The objective of this study is to to compare the CT score used to assess heart disease and the regular 
widely used clinical assesment scores known as the Framingham risk score and the NCEP Core risk 
score  in predicting cardiac events. 
 
 
 
2. Please describe if the study uses procedures already being performed on patients for 
diagnosis or treatment or if modified or novel procedures are to be used? 
Coronary CT angiogram is an established modality of imaging diseases of the heart’s 
blood vessels.  
 
 
3. Please describe what benefits might be reasonably be expected by the participant as 
an outcome of participation  
The patients taking part in the study will benefit in that the clinician treating them will 
have a one-step test to assess for coronary artery disease. It may detect severe heart 
disease in patients who may not have significant symptoms. Awareness of the extent of 
coronary artery involvement may motivate patients to actively involve themselves in 
preventive strategies like physical exercise, diet restrictions and good compliance with 
medication or undergo major procedures. 
 
 
4. Please describe what benefits to others or new knowledge might be expected as a 
result of this study 
This study may reveal the usefulness of CT coronary angiogram  to determine early 
heart disease. The results of the study will help us understand if the current scoring 
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systems are adequate or newer scoring systems need to be established to determine 
initial management of patients based on their risk factors. 
 
5. Who are to be enrolled?  
Only those who have been referred for Coronary Ct angiogram, and give informed 
consent will be enrolled. No vulnerable groups such as women, children will be enrolled. 
 
(If any vulnerable groups (e.g., pregnant women, children) are to be enrolled, please 
provide a justification for their inclusion).  
 
6. If any economically disadvantaged individuals are to be enrolled, please provide a 
justification for their inclusion.   
Not applicable 
 
 
What are the potential risks to participants in this study?  
There are no added risks to participants who undergo this study. All coronary CT 
angiograms are associated with exposure to radiation and intravenous contrast agents. 
Exposure to excessive radiation has a slight risk of developing cancer. Severe 
intravenous contrast reactions causing anaphylactic shock are very rare and our 
department is well equipped with a rapid response team and drugs to manage an 
anaphylactic reaction. Definite protocols for management of minor side effects like 
flushing, rash , contrast extravasations are already in place. Ivabradine is a selective 
heart rate lowering drug and it has minimal side effects like flushing, lightheadedness 
and dizziness. Ivabradine rarely causes visual side effects like phosphenes which are 
bright spots in field of vision which is very transient and requires no treatment. A study 
by Tanuj et al in 2008 , visual symptoms were reported by 3% of patients receiving 
ivabradine 5 mg twice daily.  
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7. Are the risks to participants reasonable in relation to the benefits that might 
reasonably be expected as an outcome to the participant or to others, or the 
importance of the knowledge that may reasonably be expected to result? Please 
provide a detailed description of the above.  
There is no added risk in taking part in the study. The risks associated with all coronary 
CT angiogram apply. These risk are reasonable in relation to the very high benefits 
associated with coronary CT angiography, as the extent of the disease involvement is 
diagnosed. This may change management or specify the need for a major procedure. It 
enables clinicians to assess if the present method of risk stratifying patients are 
accurate, or if new guidelines need to be developed. 
 
 
8. Regarding informed consent to obtained from research participants or their legally 
authorized representative(s): 
 
a. Does the informed consent document include all the required elements? Yes 
  
b. Are the participant information sheet and the consent document in language 
understandable to participants? Yes 
 
Who will obtain informed consent (PI, nurse, other?) and in what setting? 
The informed consent will be taken by the principal investigator when the patient 
comes to the department of radiology with the referral coronary CT angiogram 
 
 
c. If appropriate, is there a children’s assent? Not applicable 
 
d. Is the EC requested to waive or alter any informed consent requirement? No 
 
9. Is there provision of free treatment for research related injury? No 
 
10. Is there provision for compensation of participants for disability or death resulting 
from  
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 research related injury. No 
 
11. Is the study covered by insurance? No 
 
12. In addition to the overall budget in Section I, please provide details of the following 
a. Justification, timing and amount of payments to study participants 
b. Justification, timing and amount of payments to investigators/departments 
c. Any other study related financial or in kind incentives to participants or study staff 
There is no other payment or financial or any other kind of incentive being planned for the 
participants, the study staff, investigators and their departments. 
 
13. Please describe the plan for maintaining confidentiality of study participant 
information. 
 The study participants informatation will be saved in password protected files which 
will remain highly confidential, accessible to only the investigator and co - investigators 
 
 
14. Please describe the plans for monitoring the safety of participants, reporting and  
managing adverse events.  If this is an externally funded study with a Data Safety  
Monitoring Board, please provide the name and contact information of the DSMB  
chairperson. 
There is an already established protocol in place to report contrast reaction which is 
associated with any contrast enhance CT study. There is no increased risk in patients taking 
part in this study.  The patients who develop contrast reactions will be seen by the doctor 
posted in the CT room and the necessary medication for the same will be given based on 
the severity of the reaction. In case of contrast extravasations, Department of Hand surgery 
will be informed and the patient will be handed over for further management.  
 
 
15. If applicable; please provide all significant previous decisions (e.g., those leading to a  
negative decision or modified protocol) by other ECs or regulatory authorities for the  
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proposed study (whether in the same location or elsewhere) and an indication of the   
modification(s) to the protocol.  Not applicable 
 
16. If appropriate, has permission from the Drug Controller General of India been 
obtained? Not applicable 
 
17. If this is international collaborative research, has permission from the Health  
Ministry’s Screening Committee been obtained? Not applicable 
 
18. For exchange of biological material in international collaborative studies, please  
 provide a Memorandum of Understanding (MOU)/ Material Transfer Agreement  
 (MTA) between the collaborating partners. Not applicable 
 
 
Declaration (to be signed by all investigators) 
By signing this form we give our consent to provide our expertise to the project. In addition: 
 
We confirm that all investigators have approved this version of the protocol and have 
contributed substantially to its development.  
We confirm that all potential authors are included in this protocol.  
We confirm that we shall submit any protocol amendments, significant deviations from 
protocols, progress reports (if required) and a final report and also participate in any audit of 
this study, if required.  
We confirm that we shall conduct this study in accordance with the Declaration of Helsinki; the 
ICMR Guidelines for Biomedical Research in Human Subjects 2006, with any subsequent 
amendments; and all applicable laws of the land.  
We also agree to submit for publication to a peer reviewed journal the complete results of this 
study within two years of completion of this study.  
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We declare that we have no conflicts of interest that may affect the conduct or reporting of this 
study (OR) we declare the following conflicts of interest below. 
We are aware of the institution’s policies regarding scientific misconduct 
(Falsification/fabrication/plagiarism) and agree to abide by them. 
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Section III 
 
CHECKLIST FOR PROTOCOLS SUBMITTED TO IRB OF CMC VELLORE FOR OBSERVATIONAL 
(CASE CONTROL, COHORT & CROSS SECTIONAL) STUDIES 
 
Please tick the appropriate boxes below to indicate that the following have been submitted and 
if not, please explain why: 
 
1. Form for protocols of Observational Studies with all sections (I, and II) completed [  ] 
2. Informed consent sheet and participant information sheet in all relevant local 
languages (PDF Format) [   ]  
3. Names, affiliations and signatures of all investigators/co-investigators for the 
declaration [   ]  
4. Signature of the Head of the department or unit as applicable (for interdepartmental 
studies, an agreement letter from concerned departmental heads is desirable, 
especially if they are not co-investigators). [   ] 
5. Recent curriculum vitae of all the investigators indicating qualification and experience 
and relevant publications in the past five years. [   ]  
6. If applicable, proposed compensation and reimbursement of incidental expenses and 
management of research related and unrelated injury/ illness during and after 
research period. [ NA  ] 
7. If applicable (in study-related injuries), a description of the arrangements for 
insurance coverage for research participants and copy of insurance documents from 
an India insurance agency. [NA ] 
8. If applicable; all significant previous decisions (e.g., those leading to a negative 
decision or modified [ NA  ] protocol) by other ECs or regulatory authorities for the 
proposed study and an indication of the modification(s) to the protocol made on that 
account.  The reasons for negative decisions should be provided. [ NA  ] 
9. Plans for publication of results - positive or negative - while maintaining the privacy 
and confidentiality of the study participants, with names of proposed authors and 
their expected contributions. [   ] 
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10. All other relevant documents related to the study protocol like product information 
and statement of relevant regulatory clearances. [NA ] 
11. If applicable, any material used for advertisement to recruit participants to the study - 
this may include flyers, brochures, posters, radio and TV advertisements. [ NA ] 
12. For externally funded studies, details of Funding agency/ Sponsors and breakdown of 
fund allocation. [ NA ] 
13. One hard copy and a soft copy on CD to research@cmcvellore.ac.in of all the above. [  
] 
 
Please list below all additional documents that are being submitted along with this application 
including all appendices.  
1. Consent forms in English, Tamil, Telugu and Hindi 
2. Patient information sheet in English, Tamil, Telugu, Hindi 
3. Curriculum vitae of principal investigator, guide and co-investigators 
4. Data collection sheet 
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ANNEXURE 4: Raw data 
slno refunit referral others age dob sex smoke hyperten hyperyes diabetes cholestero cholesyes
1 crd2 3 44 03/05/1971 1 1 1 1 1 1 2
2 crd3 1 48 07/02/1967 1 2 2 2 2 1 1
3 crd2 1 hypertension 62 16/02/1953 2 2 1 2 2 1 2
4 crd2 5 73 01/07/2042 2 2 2 2 1 1 2
5 crd3 7 postive treadmil 31 05/05/1984 1 2 2 2 2 1 2
6 crd1 7 tredmil false positive 54 16/03/1961 2 2 2 2 2 1 2
7 crd2 1 59 01/07/1956 1 2 1 1 2 1 2
8 crd3 1 53 01/01/1962 1 2 2 2 2 1 1
9 crd1 1 dyspnea 34 01/07/1981 1 2 2 2 2 2
10 crd2 1 45 01/07/1970 1 2 2 2 2 1 2
11 crd2 1 43 26/08/1972 1 2 2 2 2 1 1
12 crd3 1 51 30/08/1964 2 2 1 1 2 1 1
13 crd1 1 41 18/08/1974 2 2 2 2 1 1 1
14 crd2 7 myocarditis 54 01/07/1961 2 2 1 1 2 1 2
15 crd1 7 dyspnea, TMT false positive 48 11/07/1967 2 2 2 2 2 1 2
16 crd3 42 02/01/1973 2 2 2 2 2 1 2
17 crd3 7 tmt positive inducible ischemia 44 16/05/1972 1 2 2 2 2 1 2
18 crd1 44 01/07/1971 2 2 2 2 2 1 2
19 crd3 1 45 13/05/1970 1 2 1 1 2 1 1
20 med2 1 57 13/12/1958 1 1 1 1 2 1 1
21 crd3 7 tmt positive HTN DM 38 04/05/1977 2 2 2 2 1 1 2
22 med2 1 58 01/07/1957 2 2 1 1 1 1 2
23 crd3 2 69 01/07/1946 2 2 2 2 2 1 2
24 crd3 7 dyslipidemia 44 02/01/1971 1 2 2 2 2 1 1
25 crd2 2 49 16/05/1966 2 2 2 2 2 1 2
26 crd2 2 43 26/01/1972 1 2 2 2 2 1 2
27 crd3 7 tmt positive 48 01/07/1969 2 2 1 1 2 1 1
28 crd2 7 low pretest probablity tmt positive49 06/10/1966 2 2 2 2 2 1 2
29 crd2 1 hypertension 53 18/02/1962 2 2 1 1 1 1 1
30 ch2 7 chest pain with raised troponin SLE17 01/07/1998 2 2 2 2 2 1 2
31 crd3 7 LBBB, dyslipidemia 56 14/11/1958 2 2 1 1 2 1 1
32 crd3 1 57 30/11/1957 2 2 1 1 1 1 1
33 crd3 7 dyspnea, tmt positive 44 30/05/1971 2 2 1 1 2 1 2
34 crd3 4 61 25/12/1953 2 2 1 1 1 1 2
35 crd3 7 palpitations SLE 45 01/07/1970 2 2 1 1 2 1 2
36 crd3 1 46 27/09/1969 1 2 2 2 2 1 2
37 crd3 2 50 01/07/1965 1 2 2 2 2 1 1
38 crd2 7 false pasiive thallium study 60 01/06/1955 1 2 2 2 2 1 2
39 crd1 7 dyspnea, TMT positive 36 09/05/1979 2 2 2 2 2 1 2
40 crd1 2 60 25/06/1955 2 2 2 2 2 1 1
41 crd 4 45 01/07/1970 1 2 2 2 2 1 1
42 crd2 1 56 01/07/1959 2 2 2 2 2 1 2
43 crd3 7 postive tmt 64 01/07/1951 1 2 1 1 1 1 1
44 crd3 7 44 06/06/1971 2 2 2 2 2 1 2
45 crd2 7 SPECT ischemia 25 10/06/1990 1 2 2 2 2 1 2
46 crd3 1 48 02/07/1967 2 2 1 1 2 1 2
47 crd1 7 tmt postive 53 01/07/1962 2 2 1 1 1 1 1
48 med1 4 58 12/05/1957 1 2 1 1 2 1 1
49 crd2 1 53 20/05/1962 2 2 1 1 1 1 2
 147 
 
 
treatchole heartdisea whoheartdi whichage historysig weight height bp
dia
stolic bmi bmirange totalchol ldl trigly hdl framingham
2 1 3 41 1 131 180 120 80 40.43 4 133 86 152 36 26
2 2 66 170 110 80 22.84 2 219 139 175 54 3.2
1 2 82 155 147 90 34.13 4 142 79 148 45 9.1
2 2 62 152 140 90 26.84 3 143 93 270 32 17.3
2 2 57 170 110 80 19.72 2 210 132 126 51 1
2 2 87 159 130 70 34.41 4 95 50 43 47 2.6
2 2 70 170 175 84 24.22 2 145 103 71 27 30
1 2 1 71 174 120 80 23.45 2 88 34 201 27 6.7
2 61 164 140 90 22.68 2
2 2 60 160 130 70 23.44 2 181 109 180 36 4.9
1 2 75 170 110 80 25.95 3 127 75 98 35 3.3
2 2 70 157 137 83 28.4 3 184 122 119 49 6.3
1 2 62 150 110 80 27.56 3 309 206 235 45 7.1
2 2 51 160 138 85 19.92 2 260 167 124 66 19.6
2 2 65 155 140 80 27.06 3 169 88 54 69 3.6
2 2 87 156 120 70 35.75 4 164 117 95 36 2
2 2 71 155 110 80 29.55 3 128 74 192 29 2.7
2 2 66 158 120 80 26.44 3 176 104 89 45 2.8
2 2 82 169 120 80 28.71 3 166 110 136 34 3.3
1 2 59 175 140 90 19.27 2 142 86 175 40 14
2 2 62 151 120 80 27.19 3 94 50 161 25 2.8
2 2 72 150 110 72 32 4 179 100 103 52 9.7
2 2 63 162 120 75 24.01 2 220 120 98 68 7.5
1 2 97 178 120 80 30.61 4 248 169 130 54 5.8
2 2 66 160 120 72 25.78 3 180 101 102 46 3.6
2 2 78 170 120 80 26.99 3 163 104 123 39 4.6
2 2 59 160 140 70 23.05 2 151 90 101 43 5.9
2 2 68 170 130 80 23.53 2 90 48 65 38 2.2
1 2 72 160 120 76 28.13 3 185 126 119 42 12.1
2 2 90 150 120 60 40 4 156 101 143 37 0.6
1 2 57 141 150 100 28.67 3 157 83 63 58 8.6
1 2 74 149 152 90 33.33 4 144 85 99 47 18.3
2 2 72 160 164 80 28.13 3 169 88 246 46 8.1
2 2 75 157 170 78 30.43 4 194 112 140 54 30
2 2 71 161 120 75 27.39 3 138 81 40 43 3
2 2 80 175 130 80 26.12 3 107 51 89 46 3.6
2 2 88 172 100 70 29.75 3 114 70 47 39 4.4
2 2 65 158 120 80 26.04 3 105 64 119 29 10
2 2 52 160 120 80 20.31 2 128 73 119 46 1.1
1 2 70 158 124 78 28.04 3 223 146 122 52 14.1
2 2 79 164 110 80 29.37 3 270 165 658 43 7.1
2 2 65 160 110 70 25.39 3 207 136 122 40 3.8
1 2 63 175 140 70 20.57 2 183 66 577 22 30
2 2 65 150 120 80 28.89 3 118 70 101 36 2
2 2 86 183 120 80 25.68 3 197 143 121 33 1.3
2 2 59 148 132 82 26.94 3 202 135 79 48 6.5
1 2 46 145 118 63 21.88 2 226 145 472 32 17.2
1 2 67 165 130 80 24.61 2 224 139 291 58 17.2
2 2 74 156 110 70 30.41 4 179 117 97 50 3.8
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ncep coronary calcium rca leftmain lad lcx marginal diagonal pda ri sps sis sss duke p1 p2 p3 p4 p5 p6 p7
4 1 2 2 2 1 1 2 2 2 2 4 4 4 2 4 4 4 4
1 2
2 2
3 1 2 1 2 1 2 2 2 2 2 3 3 0 2 4 3 3
1 2
1 2
4 1 2 2 2 1 2 1 1 2 2 1 3 0 0 4 4 4
2 2
2
1 2
1 2
1 2
4 2
1 2
1 2
1 2
1 2
1 2
1 2
3 2
4 2
4 2
1 1 2 2 2 1 1 2 2 2 2 2 3 0 1 4 4 4
1 2
1 2
1 2
1 1 3 1 2 1 2 2 2 2 2 2 3 0 1 4 4 4
1 2
4 2
1 2
2 2
4 2
1 2
4 2
1 2
1 2
1 2
3 1 1 2 2 2 1 2 2 2 2 1 1 0 1 4
1 2
1 2
1 2
1 2
4 2
1 2
1 2
1 2
3 2
3 1 2 2 2 1 2 1 2 2 2 1 2 0 1 3 4
4 1 2 2 1 2 2 2 2 2 2 0 1 0 1 1
 149 
 
 
50 crd3 1 31 03/03/1984 1 2 1 1 2 1 2
51 crd2 1 64 19/10/1950 2 2 1 1 1 1 1
52 crd2 2 56 05/03/1959 2 2 2 2 1 1 2
53 crd 7 54 01/07/1961 2 2 1 2 1 1 2
54 crd 7 47 01/07/1968 2 2 2 2 2 1 2
55 crd 1 33 01/07/1982 1 2 2 2 2 1 1
56 med2 4 68 14/08/2047 2 2 1 1 2 1 2
57 crd 7 44 07/07/1971 2 2 2 2 1 1 2
58 crd 1 61 24/02/1954 2 2 1 1 2 1 2
59 crd1 1 46 07/11/1968 2 2 2 2 2 1 2
60 crd1 1 63 12/12/1951 2 2 2 1 2 1 2
61 crd 1 43 01/07/1971 2 2 1 1 2 1 2
62 crd2 7 54 01/07/1961 1 2 2 2 1 1 2
63 crd2 7 58 01/07/1957 1 2 2 2 2 1 1
64 crd 2 57 19/03/1958 2 2 2 2 2 1 1
65 crd 1 triple rule out 37 22/07/1978 2 2 2 2 2 1 2
66 crd1 2 44 01/07/1971 1 2 2 2 2 1 2
67 crd 2 48 11/10/1967 2 2 2 2 2 1 2
68 crd1 1 57 01/07/1958 1 2 1 1 2 1 2
69 crd 5 76 01/07/2039 1 2 2 2 1 1 2
70 crd2 7 ventricular ectopic 54 04/05/1961 1 2 2 2 2 1 2
71 crd3 1 32 15/02/1983 1 2 2 2 2 1 1
72 crd 5 45 01/07/1970 2 2 1 1 1 1 2
73 crd2 6 37 27/07/1978 1 2 1 1 1 1 1
74 crd 1 25 02/03/1989 1 2 1 1 2 1 2
75 crd1 1 61 01/07/1954 2 2 1 1 2 1 1
76 crd1 1 30 10/03/1986 1 2 2 2 2 1 1
77 crd3 2 55 18/06/1960 2 2 2 2 2 1 1
78 crd3 4 59 01/07/1956 2 2 1 1 2 1 1
79 crd3 1 31 01/01/1984 1 2 2 2 2 1 2
80 crd2 7 tmt positive 53 01/06/1962 1 2 2 2 2 1 1
81 crd1 1 50 01/07/1965 2 2 2 2 2 2
82 crd3 1 49 01/07/1966 2 2 1 1 2 1
83 crd3 1 52 03/06/1963 2 2 2 2 2 1 2
84 crd3 1 40 11/02/1975 1 2 2 2 1 1 1
85 crd3 1 59 13/03/1956 2 2 1 1 2 1 1
86 crd2 7 inferior wall mi changes in ecg 32 01/07/1983 1 1 1 1 2 1 2
87 crd1 1 40 01/07/1975 2 2 1 1 2 1 1
88 crd1 2 chest pain to arm 56 05/04/1959 1 2 2 2 2 1 1
89 crd1 2 45 01/07/1970 2 2 1 1 2 1 2
90 crd2 6 60 03/02/1956 1 2 1 1 2 1 2
91 crd1 2 54 2 2 2 2 2 1 2
92 crd1 1 34 15/06/1981 1 2 2 2 2 1 2
93 crd3 1 39 01/01/1976 2 2 2 2 2 1 2
94 crd 1 72 30/04/1943 1 2 1 1 2 1 2
95 crd3 1 41 1 2 2 2 2 1 2
96 crd3 1 47 2 2 2 2 2 1 2
97 crd3 2 36 03/08/1979 1 2 2 2 2 1 2
98 crd2 1 57 10/04/1958 1 2 2 2 2 1 2
99 crd1 1 64 01/07/1948 1 2 1 1 1 1 1
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2 2 70 172 140 80 23.66 2 157 78 162 54 1.9
1 2 58 154 130 90 24.46 2 113 66 97 40 13.3
2 2 65 160 120 80 25.39 3 200 127 120 55 9.4
2 2 90 158 120 87 36.05 4 118 581 116 49 6.8
2 2 70 156 110 60 28.76 3 127 76 82 47 1.3
1 2 98 176 120 74 31.64 4 221 161 66 43 3.6
2 2 55 157 160 100 22.31 2 120 54 53 50 12.7
2 2 60 158 120 80 24.03 2 144 98 89 44 5.8
2 2 55 155 130 70 22.89 2 163 109 91 44 8.9
2 2 60 160 130 90 23.44 2 179 110 167 41 4.1
2 2 60 156 104 63 24.65 2 185 101 150 64 3.5
2 2 60 155 116 72 24.97 3 183 123 127 35 4
2 2 62 179 100 80 19.35 2 134 92 88 28 12.2
2 2 72 168 158 87 25.51 3 157 93 155 48 14.7
1 2 65 154 130 70 27.41 3 167 98 138 53 5.2
2 2 75 152 109 73 32.46 4 183 118 73 54 1.3
2 2 63 160 110 70 24.61 2 138 88 87 36 1.9
2 2 67 167 100 63 24.02 2 135 62 71 66 1.1
2 2 60 160 110 70 23.44 2 185 118 236 33 16
1 2 68 170 100 66 23.53 2 145 74 63 71 15
2 2 93 190 120 80 25.76 3 167 110 99 44 8.4
1 2 77 172 120 70 26.03 3 550 409 499 24 19
2 2 114 158 140 90 45.67 4 152 82 245 31 12.4
1 2 74 175 121 73 24.16 2 98 61 113 28 5.5
2 2 68 172 130 86 22.99 2 170 103 213 37 1.6
1 2 64 154 130 90 26.99 3 145 78 114 52 6.9
2 2 60 148 120 70 27.39 3 207 129 121 53 1.2
2 2 87 162 125 79 33.15 4 206 95 84 94 3.7
1 2 74 163 129 80 27.85 3 197 111 179 61 6.6
2 2 88 181 102 63 26.86 3 131 71 183 40 1.3
1 2 80 174 121 71 26.42 3 181 103 154 33 11
2 73 154 130 80 30.78 4 326 232 76 63 7.5
2 2 83 155 128 90 34.55 4 135 60 131 50 3.4
2 2 100 170 130 80 34.6 4 126 71 283 71 8.5
1 2 58 149 140 80 26.12 3 195 114 104 39 13.4
2 2 100 176 120 80 32.28 4 146 87 153 25 6.5
2 2 70 154 110 80 29.52 3 211 126 85 47 2.8
1 2 70 174 120 80 23.12 2 189 114 155 39 12.4
2 2 65 156 130 80 26.71 3 162 98 163 31 5.7
2 2 70 170 138 78 24.22 2 188 104 76 51 19
2 2 60 145 136 80 28.54 3 187 120 122 40 7.2
2 2 63 174 130 90 20.81 2 126 57 109 67 1.3
2 2 69 151 119 77 30.26 4 147 81 148 43 1.6
2 2 65 170 130 80 22.49 2 202 115 51 52 30
2 2 83 178 145 75 26.2 3 151 96 131 36 5.8
2 2 52 150 108 76 23.11 2 167 94 63 60 1.8
2 2 65 170 100 90 22.49 2 169 114 125 28 2.3
68 170 120 90 23.53 2 191 108 75 52 9.8
1 2 62 177 107 62 19.79 2 99 47 92 40 28
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1 2
4 1 3 2 2 1 1 2 2 2 2
4 2
4 2
1 2
1 2
2 2
4 2
1 2
1 2
1 2
2 2
4 1 2 2 2 1 2 2 2 2 2 1 1 0 1 4
1 2
1 2
1 2
1 2
1 2
3 2
4 1 4 1 2 1 1 2 2 1 1 18 7 7 3
1 2
1 1 2 1 2 1 1 2 2 2 2 5 5 0 1 4 3 4 3 4
4 2
3 2
2 2
2 1 1 1 2 2 2 2 2 2 2 0 3 0 1 2
1 2
1 2
2 2
1 2
3 2
1 2
1 2
4 2
2 1 2 2 1 1 2 2 2 2 2 0 3 0 2 4 4 1
2 2
1 1 2 2 1 2 1 2 2 2 2 0 2 0 0 4 4
1 1 3 1 1 1 2 2 2 2 2 2 3 1 1 4 3 3
1 1 2 1 2 1 2 2 2 2 2 1 2 1 1 3 4
3 1 2 1 2 1 2 2 2 2 2 2 2 2 1 4 4
1 2
1 2
1 2
4 1 2 1 2 2 2 2 2 2 2 2 1 2 2 3
2 2
1 2
1 2
1 2
4 2
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100 crd3 1 41 25/01/1945 1 2 2 2 2 1 2
101 cd3 1 52 01/07/1963 2 2 1 1 1 1 1
102 crd3 1 46 28/01/2016 2 2 1 1 2 1 2
103 crd2 1 42 02/03/1973 2 2 2 2 2 1 2
104 crd3 1 27 01/07/1988 1 2 2 2 2 1 2
105 crd3 1 50 31/01/1965 1 2 2 2 2 1 1
106 crd3 1 60 10/08/1955 2 2 1 1 2 1 1
107 med5 1 41 01/07/1974 2 2 2 2 2 1 2
108 crd3 1 62 08/04/1953 2 2 2 2 1 1 1
109 med1 7 breathing difficulty 65 01/07/1950 2 2 1 1 1 1 1
110 4 76 10/07/1939 1 1 1 1 2 1 1
111 crd3 1 52 01/07/1963 1 2 1 1 2 1 1
112 med2 1 50 19/07/1965 1 2 2 2 2 1 1
113 crd3 4 71 01/07/1945 1 2 1 1 1 1 1
114 crd3 2 40 06/05/1975 1 2 1 1 2 1 1
115 crd3 1 64 01/01/1952 1 2 1 1 2 1 1
116 crd3 1 50 01/07/1965 2 2 2 2 2 1 1
117 epc 1 68 01/07/1947 1 2 1 1 2 1 2
118 crd2 1 61 01/07/1954 2 2 2 2 2 2
119 crd2 1 61 21/05/1955 2 2 2 2 2 1 2
120 med2 1 59 01/03/1956 1 1 1 1 2 1 1
121 crd3 4 36 06/10/1979 1 2 1 1 2 1 1
122 crd3 1 54 07/04/1962 2 2 2 2 2 1 1
123 epc 1 60 01/07/1955 1 2 2 2 2 1 2
124 crd3 1 56 24/08/1959 2 2 1 1 2 1 1
125 crd3 1 54 01/07/1960 2 2 2 2 2 1 1
126 epc 1 62 12/11/1953 1 2 1 1 2 1 1
127 crd2 4 68 01/07/1947 2 2 1 1 2 1 1
128 crd3 4 49 01/07/1969 2 2 1 1 1 1 1
129 crd1 1 66 01/07/1947 1 2 1 1 1 1 2
130 epc 1 42 01/07/1973 1 2 2 2 1 1 1
131 crd3 1 38 01/07/1977 2 2 1 1 2 1 2
132 crd1 1 39 02/02/1977 1 2 1 1 2 1 1
133 crd3 1 47 22/05/1969 2 2 2 2 2 1 2
134 epc 1 67 01/07/1949 1 2 2 2 1 1 2
135 crd3 1 53 10/02/1963 2 2 1 1 2 1 1
136 crd3 7 transient ecg changes 35 01/07/1980 1 2 2 2 2 2
137 crd3 2 41 05/02/1975 2 2 2 2 1 1 1
138 crd3 4 52 05/11/1962 2 2 1 1 1 1 1
139 crd2 1 60 12/09/1955 2 2 1 1 1 1 1
140 crd1 1 45 01/07/1970 2 2 1 1 2 1 2
141 epc 4 68 11/04/1948 2 2 1 1 2 1 2
142 epc 4 family history 56 01/07/1959 2 2 1 1 2 1 2
143 crd3 4 40 10/09/1975 2 2 1 1 1 1 1
144 med2 2 40 19/04/1976 2 2 1 1 2 1 2
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2 2 83 175 129 79 27.1 3 151 96 131 36 4.2
2 2 75 155 142 74 31.22 4 145 90 60 38 10.8
2 2 65 150 100 70 28.89 3 185 126 107 38 1.7
2 2 68 159 130 90 26.9 3 158 92 118 43 2.1
2 2 85 170 120 80 29.41 3 175 109 183 34 1.3
2 2 72 180 141 75 22.22 2 217 164 95 39 7.9
1 2 55 156 121 73 22.6 2 246 145 182 40 12.1
2 2 60 164 100 60 22.31 2 128 76 56 59 1
1 2 65 150 120 80 28.89 3 99 42 82 52 5.2
1 2 77 148 140 90 35.15 4 204 134 77 56
1 2 60 166 110 70 21.77 2 226 140 93 53 30
1 2 80 166 123 72 29.03 3 106 56 107 44 5.5
1 2 64 165 130 80 23.51 2 144 75 86 55 5.4
1 2 80 170 129 80 27.68 3 157 92 97 60 30
2 2 79 165 130 80 29.02 3 189 250 53 105 5.3
1 2 68 172 131 73 22.99 2 126 69 152 42 16
1 2 63 154 116 75 26.56 3 189 117 185 35 4.2
2 2 44 161 150 70 16.97 1 180 112 73 45 30
2 56 158 111 78 22.43 2 207 120 193 57 4.5
2 2 49 145 140 80 23.31 2 194 133 98 49 9.4
1 2 51 155 130 80 21.23 2 153 92 120 33 30
1 2 66 167 121 76 23.67 2 252 161 235 42 5.7
1 2 54 150 100 60 24 2 144 83 91 48 2.4
2 2 90 177 108 73 28.73 3 175 125 159 32 13
1 2 68 160 110 70 26.56 3 174 110 100 54 4.4
2 2 67 152 125 78 29 3 275 178 291 59 7
1 2 69 166 130 78 25.04 3 149 98 90 42 19
1 2 65 154 140 79 27.41 3 160 84 85 72 11.4
1 2 67 156 100 60 27.53 3 147 84 90 51 5.4
1 2 70 173 122 87 23.39 2 93 63 33 51 19.6
1 2 55 162 130 90 20.96 2 168 173 91 45 5.7
2 2 76 160 150 90 29.69 3 217 153 103 50 5.8
1 2 76 170 130 80 26.3 3 201 128 109 48 5.3
2 2 57 157 120 90 23.12 2 125 79 95 35 2.5
2 2 64 170 129 79 22.15 2 119 63 141 40 22
1 2 61 158 137 75 24.44 2 176 119 180 43 8.4
2 77 176 90 60 24.86 2 138 85 121 34 1.4
1 2 72 166 106 75 26.13 3 266 149 608 47 4.5
1 2 88 164 140 80 32.72 4 175 115 105 42 17
1 2 65 146 114 78 30.49 4 110 67 45 48 7.3
2 2 62 150 140 90 27.56 3 147 78 172 43 4.9
2 2 68 154 136 78 28.67 3 145 78 172 43 11.3
2 1 1 80 2 75 160 110 60 29.3 3 193 117 140 42 5.9
1 2 76 154 106 70 32.05 4 178 110 213 34 5.1
2 2 59 156 100 80 24.24 2 164 112 103 33 2.6
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